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1. Abstract 
Lytic granule (LG)-mediated apoptosis is the main mechanism by which cytotoxic T 
lymphocytes (CTLs) kill virus-infected and tumorigenic target cells. CTLs form a tight 
junction with the target cells called immunological synapse (IS). T cell receptors (TCR) are 
then quickly enriched at the IS. Lytic granules are also transported to the IS where they 
release their cytolytic contents inducing target apoptosis. To avoid unwanted killing of 
neighboring cells, exocytosis of lytic granules is tightly controlled and restricted to the IS. 
During my thesis work, I discovered the interaction of lytic granules with recycling TCR 
compartments (rTCR). This interaction is important for the accumulation and release of 
lytic granules at the IS as well as for CTL-mediated cytotoxic function. Lytic granules 
pair/tether with recycling TCR compartments in resting and conjugated CTLs. After target 
cell recognition, the paired lytic graules and recycling TCR compartments are co-
transported to the IS, where recycling TCR compartments are required for the docking and 
release of lytic granules.  
To search for the molecular mechanism of pairing, we screened SNARE proteins. We 
found that LG/rTCR pairs colocalize with the Qb-SNARE protein Vti1b. Down regulation 
of Vti1b by the RNA interference reduces the interaction of lytic granules and recycling 
TCR compartments. Consequently, accumulation of lytic granules at the IS and CTL-
mediated cytotoxicity are also impaired in Vti1b-downregulated CTLs. Our data establish 
that the Vti1b-dependent interaction between lytic granules and recycling TCR 
compartments is required for CTL-mediated target cell killing.  
To better understand the function of LG/rTCR pairing, a compartment model was 
formulated in co-operation with Prof. Heiko Rieger (Theoretical Physics, Saarbrücken), 
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based on the results from confocal microscopy experiments. The data showed that the rate 
of paired LG leaving the IS is much lower than the rate of paired LG approaching the IS, 
resulting in the accumulation of paired LG at the IS. In contrast, there is not much 
difference between the back and forward rate of single lytic granules. In addition, we 
determined for the first time the generation of new lytic granules in vivo after target cell 
recognition.  
In summary, our data establish the tethering/pairing of LG and eTCR as a mechanism of 
rapid and efficient CTL-mediated target cell killing. The Qb-SNARE protein Vti1b is 
necessary for the interaction between LG and eTCR. This close interaction between LG 
and eTCR is required for the accumulation and secretion of LG at the IS. Vti1b down 
regulation by RNA interference decreased the probability of the interaction between LG 
and eTCR. As a result, LG accumulation and release at the IS were impaired and CTL-
mediated cytotoxicity was reduced. This pairing mechanism sheds new light on 
understanding strictly controlled reorientation of lytic granules and CTL-mediated 
cytotoxicity.  
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1.  Zusammenfasung 
Zytotoxischen T-Lymphoyzten (ZTL) töten Tumor- oder virusinfizierte Zellen 
hauptsächlich durch Apoptose, die durch die Inhaltsstoffe lytischer Granula (LG) 
vermittelt wird. Dabei bilden sie einen engen Kontakt mit ihren Zielzellen aus, die 
sogenannte Immunologische Synapse (IS), die unter anderem durch die Anreicherung von 
T-Zellrezeptoren (TZR) charakterisiert ist.  Die LG werden zur IS transportiert, wo sie 
fusionieren und die Apoptose durch die Entleerung ihrer zytotoxischen Inhaltsstoffe in der 
Zielzelle auslösen. Um eine unerwünschte Abtötung benachbarter Zellen zu verhindern, 
muss die Exozytose der LG streng reguliert werden und darf nur an der IS stattfinden. Ich 
habe herausgefunden, dass LG mit intrazellulären Kompartimenten, die endozytierte T-
Zellrezeptoren (eTZR) enthalten, interagieren. Diese Interaktion (oder auch Paarung 
zwischen den verschiedenen Organellen) ist unerlässlich für die Anreicherung und die 
Freisetzung der LG an der IS und damit für die Zytotoxizität der ZTL. Die LG können 
sowohl in ruhenden als auch in aktivierten ZTL mit den eTZR interagieren. Nach dem 
Kontakt mit einer Zielzelle werden die gepaarten LG/eTCR Kompartimente zusammen zur 
IS transportiert, wobei die eTZR Kompartimente notwendig für die Akkumulation und die 
Freisetzung der LG sind. 
Um den molekularen Mechanismus der Interaktion besser zu verstehen, haben wir die 
Expression und Lokalisation vieler SNARE Proteine untersucht. Wir haben 
herausgefunden, dass LG/eTZR Kompartimente mit dem Qb-SNARE Protein Vti1b 
kolokalisieren. Eine Herunterregulation der Vti1b-Expression mittels siRNA-Technologie 
führt zu einer Reduktion der Anzahl der gepaarten LG/eTZR Kompartimente.  Im 
Folgenden wird auch die Akkumulation der LG an der IS reduziert und dadurch die 
Zytotoxizität der ZTL erniedrigt. Diese Daten belegen, dass die Vti1b-abhängige 
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Interaktion zwischen LG und eTZR Kompartimenten für die Induktion der Apoptose in 
den Zielzellen notwendig ist. 
Um die Funktion der LG/eTZR Kompartimente genauer zu analysieren, haben wir in 
Zusammenarbeit mit Prof. Heiko Rieger (Theoretische Physik, Saarbrücken), basierend auf 
unseren Konfokalmikroskopiedaten, ein sogenanntes Kompartimente-Modell entwickelt. 
Das Modell sagt unter anderem voraus, dass mit eTZR gepaarte LG eine geringere 
Wahrscheinlichkeit haben, von der IS wieder ins Zytosol zurücktransportiert zu werden als 
ungepaarte LG. Ebenfalls konnte mit Hilfe dieses Modells erstmalig in vivo die 
Neubildungsrate von LG nach Kontakt mit einer Zielzelle bestimmt werden. 
Zusammenfassend kann man festhalten, dass die Interaktion/Paarung zwischen LG und 
eTZR Kompartimenten einen neuartigen Mechanismus darstellt, um eine schnelle und 
effiziente Abtötung von Zielzellen durch ZTL zu ermöglichen. Dabei ist das Qb-SNARE 
Protein Vti1b notwendig für die Interaktion zwischen LG und eTZR Kompartimenten. Die 
enge Interaktion zwischen LG und eTZR Kompartimenten ist entscheidend für die 
Anreicherung und Freisetzung von LG an der IS. Die Herunterregulierung der Vti1b-
Expression mittels RNA-Interferenz erniedrigt die Wahrscheinlichkeit einer Interaktion 
zwischen LG und eTZR Kompartimenten. Nachfolgend wird die Akkumulation von LG an 
der Synapse inhibiert und dadurch die Zytotoxizität der ZTL reduziert. Der 
Interaktionsmechanismus zwischen LG und eTZR liefert ein besseres molekulares 
Verständnis dafür, wie LG streng kontrolliert  an der IS lokalisieren, und damit ein 
besseres Verständnis für die ZTL vermittelte, LG-abhängige Zytotoxizität. 
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2. Introduction 
2.1   Immune system: a sophisticated orchestra 
The environment we are living in is filled with many potential pathogenic microorganisms. 
To fight against invaders, we have the immune system, which comprises a variety of cell 
types and proteins, working constantly regardless of the circumstances. A host defense 
system was already present in protozoans 2.5 billion years ago. New antipathogen devices 
have been constantly evolved in eukaryotes. In return, microorganisms also continually 
evolve new ways to evade host defense tactics. With this so-called host-versus-pathogen 
arms race, the most complicated and efficient immune system has been evolved in 
mammals 1-2.    
Picture what happens when a five-year-old girl gets her finger pricked with a rose throne 
while playing in the garden. Within minutes or immediately after bleeding stops, the 
immune system sets off to eliminate the undesirable microbes introduced into the wound. 
The first response is executed by the innate immune system. The cells that belong to the 
innate immune system are already active even before invaders appear. Innate immunity 
depends on germline-encoded receptors that have evolved to recognize highly conserved 
pathogen-associated molecular patterns. Therefore the innate immune system is 
functioning in a generic, non-specific manner 3-4. Innate immunity sometimes suffices to 
destroy invading microbes. If it does not, the girl relies on another system: acquired 
immune system. 
The cells of the acquired immune system are specialized white blood cells, called 
lymphocytes. Patrolling the blood and lymph nodes, lymphocytes are normally at quiescent. 
But when they recognize foreign non-self antigens via the receptors on the plasma 
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membrane, they become activated and start to proliferate. Lymphocytes can be divided into 
two major classes, B cells and T cells, which are both derived from hematopoietic stem 
cells in the bone marrow. B cells produce and secrete antibodies, which then bind to 
antigens to neutralize them or mark them for elimination. The human body contains more 
than 100 billion B lymphocytes, each lineage of B cell expresses a different antibody, so 
the complete set of B cell antigen receptors represent all the antibodies that the body 
produces 5-6.  
T cells serve a variety of purposes: they recognize and kill cells bearing non-self molecules 
on their surface and they also help B lymphocytes produce antibodies. T cells only 
recognize the “non-self” antigens that have been processed and presented in combination 
with a major histocompatibility complex (MHC) molecule. There are two major subtypes 
of T cells: helper T cells and killer T cells. The helper T cells only recognize antigens 
bound to class II MHC molecules, while the killer T cell only recognize antigens bound to 
class I MHC molecules 7.  
Helper T cells regulate both the innate and adaptive immune responses and help determine 
which types of immune responses the body will make to a particular pathogen. These cells 
have no cytotoxic or phagocytic activity and do not kill infected cells or clear pathogens 
directly. They instead control the immune response by directing other cells to perform 
these tasks. They are essential for determining B cell antibody class switching, for the 
activation and growth of killer T cells, and for maximizing bactericidal activity of 
phagocytes such as macrophages 7-8.  
Killer T cells are also known as cytotoxic T lymphocytes (CTLs). Normally CTLs have 
CD8 molecules on the plasma membrane. They can eliminate pathogen-infected somatic 
cells and tumorigenic cells by destruction of target cells. Before killer T cells encounter the 
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corresponding antigen-presented target cells they are naive T cells and not yet killing 
competent. Once killer T cells recognize the target cells, they form a stable contact with 
the target cells. T cell receptors (TCR) are then activated to trigger downstream signaling 
pathways. It takes a few days for naive T cells to become killing competent effetor killer T 
cells – CTLs 7,9-10. The main focus of this study is on CTL-mediated cytotoxicity, in 
particular the precisely controlled release of cytotoxic granules.  
 
2.2  Cytotoxic T lymphocytes: all roads lead to death 
Both, the innate immune system and the adaptive immune system have their own killer 
cells: nature killer cells (NK cells) and cytotoxic T lymphocytes (CTLs) 11. As a part of 
innate immune system, NK cells are constantly active, eliminating target cells in an 
antigen-unspecific manner. In contrast, each CTL lineage has unique T cell receptors 
(TCR), which are activated only by certain antigens 11.  
Before CTLs encounter the corresponding antigens, they patroll the peripheral blood 
system and lymphoid system 12. In the lymph nodes, they examine all the accessible 
professional antigen-presenting cells, such as dendritic cells, macrophages and B cells 13. 
The professional antigen-presenting cells are responsible for processing the antigens from 
the non-self invaders and presenting these antigens (or parts of them) on their MHC 
molecules. Once antigens bound to the class I MHC molecules are recognized by matching 
TCR, the corresponding naive CTLs will be activated and begin the proliferation and 
maturation process 14-15. It takes 5-8 days for the activated CTLs to become fully mature 
and killing competent11. During this period, helper T cells secrete certain cytokines to 
facilitate CTL proliferation and maturation 7.        
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There are three known pathways in CTLs to destroy target cells. First and foremost, is the 
granule-mediated cytotoxicity 16-17. Usually lysosomes function as protein degradation 
organelles, but lysosomes in CTLs are further specialized to work as secretory lytic 
granules for secretion 18. The secretory lytic granules, also known as cytotoxic granules, 
are loaded with various cytotoxic proteins, such as the pore-forming protein perforin and 
the serine proteases called granzymes 18. When CTLs encounter target cells, these 
secretory lytic granules are quickly reoriented towards the interface of CTLs and target 
cells 19.  Calcium (or Ca2+) influx triggers the secretion of lytic granule to the tightly sealed 
cleft between the CTLs and their target cells 20. Cytotoxic proteins then enter target cells 
and cleave the substrate proteins, mostly caspases, to induce the apoptosis of target cells21.   
The second pathway involved in target cell elimination is the Fas (CD95, a member of the 
tumour-necrosis factor receptor family of death receptors) pathway which requires neither 
calcium influx nor perforin 22-23. The Fas molecule has a ‘death’ domain in its cytoplasmic 
tail. The engagement of the extra-cellular domain of the Fas monomer by Fas ligand on 
target tells results in the formation of a Fas trimer and activation of the cytosolic death 
domain. Trimmerization of Fas triggers the activation of capase-dependent pathway and 
the apoptosis of target cells 24.  
As a complement to these two death-inducing strategies, several cytokines are secreted by 
CTLs, such as tumor-necrosis factor (TNF) and interferon-γ (IFN-γ), which mediate 
cytotoxic actions on target cells in the vicinity 25-26.  
Among these three strategies, granule-mediated cytotoxicity is the most important and 
most commonly used pathway in CTLs to destroy target cells. The other two pathways are 
maintained as backups. Only when the granule-mediated cytotoxicity pathway is 
compromised, do the other two pathways have a significant impact on the destruction of 
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target cells 21. Therefore, in this study we focus particularly on granule-mediated 
cytotoxicity.  
 
2.3  Lytic granules: lethal kisses  
To efficiently eliminate pathogen-infected or tumorigenic cells, dozens of cytotoxic 
proteins are loaded into secretory lytic granules. These cytotoxic proteins mainly belong to 
two major classes: membrane perturbing proteins and serine proteases.  
2.3.1 Perforin 
Perforin was first identified in 1985 and characterized as a calcium-dependent, pore-
forming cytolytic protein 27-29. Perforin is comprised of a cleavable leader peptide that 
directs perforin into the secretory lysosomes, and a positively charged N-terminal sequence 
30. The calcium-dependent CD2 domain, which is essential for membrane binding of 
perforin, is located at the C-terminus 31. The final 20 amino acids of perforin contain an N-
glycosylation site and a putative cleavage site, which are thought to be important for 
perforin activation 32.  
Unlike the prosperous family of granzymes, perforin has no known isoforms. In fact, 
perforin has shown very little amino acid similarity to any other known proteins 33. Such 
uniqueness suggests that perforin has some very essential non-redundant biological 
properties. Extensive studies using perforin knockout mice have revealed that perforin is 
required to maintain immune homeostasis and immune surveillance 34-38. When perforin-
deficient mice were challenged with external pathogens, they exhibit a lymphoproliferative 
disorder and failed to eliminate pathogen-infected and/or transformed cells, which finally 
leads to spontaneous lymphoma 37,39-42. In humans, perforin has been found to be 
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associated with a life-threatening immune disorder ― familial haemophagocytic 
lymphohistiocytosis (FHL) ― which is characterized by uncontrolled T lymphocyte and 
macrophage activation with a severe hyperinflammatory phenotype 43-44. Dozens of 
mutations in perforin were identified in FHL patients and were considered to be the 
primary cause of the disease in up to 60% of the cases 33.  
 
2.3.2 Granzymes 
Eleven granzymes in mice and five granzymes in humans have been found. Granzyme A 
and B are the most redundant granzymes in mice and humans and have received the most 
attention 45. Granzyme A is a tryptase that induces caspase-independent cell death, which 
is a distinct pathway from granzyme B-mediated cell apoptosis 46-47.  Although granzyme 
A was the first granzymes to be described, much less is known about it than about 
Granzyme B 48. Granzyme A has long been thought to activate a slow cell-death pathway, 
because the oligonucleosomal DNA fragments released from the cells transfected with 
granzyme A and perforin cannot be detected until 16 hours after treatment, a timescale that 
is similar to slow cell-death pathway initiated by ligating cell-surface death receptors49-50. 
However, later studies showed that the features of apoptosis ― membrane blebbing, 
mitochondrial dysfunction and loss of plasma membrane integrity ― appeared within 
minutes in cells treated with recombinant granzyme A and perforin 51. One explanation of 
this discrepancy is that DNA is less damaged by granzyme A than by an equivalent amount 
of granzyme B, therefore the DNA fragments are too large to be released quickly from the 
nucleus into culture supernatants 45.  
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Unlike the other serine proteases, granzyme B cleaves after aspartic acid residues, like the 
caspases 52-53. It activates caspase-mediated apoptosis by cleaving caspases, particularly the 
key executioner caspase-3 54-55 or by directly cutting downstream caspase substrates 56-58. 
The activation of the caspase cascade is not the only pathway used by granzyme B to 
induce target cell death. Even when the caspase activity is completely blocked, granzyme 
B-mediated cell apoptosis is fully functional59-61. By cleaving BID (BH3-interacting 
domain death agonist), granzyme B can destroy the integrity of the mitochondrial outer 
membrane and thereby initiate the mitochondria-mediated apoptosis pathway 62-65. 
Moreover, granzyme B can directly unleash the caspase-activated DNase (CAD) by 
directly cleaving its inhibitor ICAD 59,66.  
 
2.3.3 Cooperation between perforin and granzymes 
Perforin was thought to be able to induce target cell apoptosis itself by forming poly-
perforin pores on the plasma membrane of target cells, which results in osmotic instability 
and loss of intracellular contents 67. However, the discovery of the pro-apoptotic activity of 
the granzymes altered this model. It is no debate that perforin is required for granzymes to 
execute their functions in target cells, because both CTLs and NK cells from perforin-
deficient mice completely lose the ability to kill target cells 36. But how exactly perforin 
cooperates with granzymes is still an enigma. One model is that the transmembrane pores 
formed by perforin act as passive channels for granzymes to enter target cells, which has 
been challenged by the fact that granzymes can enter target cells by endocytosis 
independently of perforin 68-69. Another model is that perforin is irrelevant to granzyme 
entry target cells but it facilitates granzymes to escape from the endocytosed compartments 
into the cytosol. This model receives support from the finding that, without perforin, 
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granzymes can still be endocytosed but cannot kill target cells 70-71. Similar to this model, 
another model was developed, which suggests that the mannose 6-phosphate receptor can 
function as a candidate surface receptor to mediate the endocytosis of granzymes, 
particularly granzyme B, by internalizing the serglycin-based granzyme-bound macro-
molecular complex 72-73.  
 
2.3.4  Why CTLs remain intact after the lethal kiss delivery 
Perforin and granzymes exhibit potent abilities to destroy target cells both externally and 
internally. However, perforin and granzymes are completely innocuous to the host cells 
that synthesize, store and secret them. How can such a duality be achieved? How could 
killer cells protect themselves from lethal hits of cytotoxic proteins?  
The first essential step for perforin to form pores is to coordinate calcium ions with its C2 
domain, which is required to bind to the phospholipids membrane 74-75.  In fact at least 200 
µM of free calcium is required to maximize membrane binding capacity of perforin and 
thereby to achieve full cytolytic activity 31. But in resting cells there is only 50-200 nΜ 
free calcium and moreover, even in activated degranulating killer cells the cytosol free 
calcium concentration never exceeds 2-5 µM 76. The physiological intracellular calcium 
concentration makes it impossible for perforin to bind calcium, which is the prerequisite 
for poly-perforin-pore formation. In addition, perforin has been shown to bind to the lipid 
bilayer only when the pH > 6.2 31. Therefore the acidic environment of secretory lytic 
granules is a safeguard to restrain the cytolytic activity of perforin.  
Another way CTLs protect themselves is by expressing granzyme-specific inhibitors, 
members of the serpin (serine proteinase inhibitor) superfamily 77. For example, the 
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intracellular inhibitor of human granzyme B, proteinase inhibitor-9 (PI-9), is expressed in 
lymphocytes 77-78 and is up-regulated by modulators of inflammation like lipopoly-
saccharide, IFN-γ and IL-1β 79-80. In case some granzymes inadvertently re-enter CTLs, 
serpins can inactivate their targets either by covalently and irreversibly binding to the 
active site of the enzyme or by forming noncovalent complexes 81-82.    
A lysosomal protein, cathepsin B, which remains at the outer plasma membrane after 
granule release, can also protect CTLs from self-destruction by cleaving perforin following 
its release into the synaptic cleft 83. Moreover, the lytic granules contain the Ca2+-binding 
protein and chaperone calreticulin, which binds to perforin and potently inhibits perforin-
mediated damage 84-85. Calreticulin might protect lytic granules from autolysis by perforin 
polymerization, but whether it plays also an inhibitory role after granule exocytosis is still 
unclear 45.   
 
2.4  The immunological synapse: face to face 
2.4.1 T cell receptors 
Successful elimination of ‘non-self’ invaders or ‘altered-self’ somatic cells by CTLs 
requires that antigens presented on those cells must be recognized by cognate T cell 
receptors (TCR). TCR activation induces downstream signaling and an effective cytotoxic 
response. TCR initiates a plethora of pathways, thereby regulating diverse cellular 
functions such as proliferation, differentiation and apoptosis 86. The TCR polypeptides 
themselves have very short cytoplasmic tails, and all proximal signaling events are 
mediated through the CD3 molecules, which comprises γ, δ, ε and the disulfide linked ζ−ζ 
chains 87.  
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The TCR/CD3 complex plays a pivotal role in mediating cell recognition events. TCR 
engagement by antigens triggers the tyrosine phosphorylation of so-called ITAMs 
(immuno-receptor tyrosine-based activation motif), which are present in the TCR-
associated CD3 complexes 88-90. ITAMs function by orchestrating the sequential activation 
of the Src-related PTKs, Lck and Fyn 91-92, which initiate TCR signaling, followed by 
ZAP70, which further amplifies the response 93-95. Various proteins are then 
phosphorylated, including the transmembrane adaptors LAT (Linker Activator for T-Cells) 
and cytoplasmic adaptor SLP-76 (SH2-domain-containing leukocyte protein of 76kDa) 96-
97. Protein tyrosine phosphorylation subsequently leads to the activation of multiple 
pathways, including ERK (extracellular signal regulated kinase), JNK (c-Jun N-terminal 
kinase), NF-KappaB  (nuclear factor-KappaB) and NFAT (nuclear factor of activated T-
cells) pathways, which ultimately induce effector functions 98-101. 
During the IS formation, TCR are quickly polarized and enriched at the IS. This 
enrichment of TCR is a necessary step to recruit effecter molecules and initiate 
downstream signaling, which eventually leads to the apoptosis of target cells 102-103. TCR 
recycling is essential for targeting TCR to the IS 104-106. TCR are internalized and recycled 
back to the cell surface in both constitutive and antigen-dependent manner 107-110. When 
TCR recycling is blocked, the enrichment of TCR at the IS is drastically reduced 104-106.  
 
2.4.2 Immunological synapse formation 
The word ‘synapse’ is derived from the Greek words, which means ‘junction’ or 
‘connection’ between two similar entities. It is used commonly to describe neuronal 
connections. The ‘immunological synapse’ (IS) was termed by Michael Dustin to describe 
the interactions between T cells and their target cells 111. One prominent feature of the 
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immunological synapse is that the spatial segregation of several proteins patterns as a well-
organized doughnut-like structure, termed supra-molecular activation complexes (SMACs). 
The center region of the SMAC (cSMAC) is enriched in TCR and one of its downstream 
effector molecules, protein kinase C-θ (PKC-θ) 112. Surrounding cSMAC is a peripheral 
ring, pSMAC, which is dominated by adhesion molecules ⎯ integrin leukocyte function-
associated antigen 1 (LFA1) and cytoskeletal linker talin 112. The pSMAC is encircled by 
large and bulky molecules, CD43 and CD45, locating in a region distal to the synapse ⎯ 
dSMAC 112.  
After target cell recognition, a drastic rearrangement takes place in T cells to establish the 
IS. Within minutes after T-cell recognition of a target cell, signals that emanate from the 
TCR lead to rapid cytoskeleton polarization, which involves F-actin polymerization 113-114 
and the reorientation of microtubule-organization center (MTOC) and Golgi apparatus 
towards the T cell-target cell interface 115. TCR are also rapidly transported towards and 
enriched at the IS 112,116. Lytic granules, the cytotoxic protein carriers, are also relocated 
and accumulated at the IS 19.  
The T-cell cytoskeleton is composed of actin filaments, microtubules and intermediate 
filaments 117. The T cell-target cell interaction leads to rapid F-actin polymerization in the 
form of a lamellipodium structure, which increases the interactive interface between the T 
cell and the target cell. The lamellipodium then contracts, leaving F-actin redistributed at 
the interface between the T cell and the target cell 113-114. During IS formation, an actin-
rich structure known as the distal-pole complex on the opposing side of the cell emerges118. 
Disruption of F-actin itself or the depletion of cytoskeletal regulators impairs IS formation 
and T-cell activation 114,119-120. In addition, CD3ζ (also known as CD247) has been shown 
to associate with the T cell cytoskeleton 121-122. Many studies have shown that numerous 
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TCR-activated signaling molecules are required for actin accumulation at the IS, including 
the TCR-proximal kinases lck, ZAP70 123, ITK (interleukin-2-inducible T-cell kinase) 124-
125, calcium signaling 113 and the adaptors LAT and SLP76 126-127. Moreover, deficiencies 
of key actin-regulatory proteins ⎯ for example, WASP (Wiskott-Aldrich syndrome 
protein), VAV1 and WIP (WASP-interacting protein) ⎯ result in profound defects in 
lymphocyte activation and development 128-130.  
Similar to the actin rearrangement during IS formation, the MTOC (or centrosome) 
relocalization in T cells also requires many signaling molecules, including Lck, FYN, 
ZAP70, LAT, SLP76, VAV1, CDC42 and intracellular calcium 131-135. MTOC 
reorientation appears to control the directed secretion of lytic granules, which might travel 
along microtubules in a minus-end-directed manner to the centrosome 136. Whether contact 
between the centrosome and the plasma membrane in CTLs is necessary for the delivery of 
lytic granules to the IS, as suggested by Sinchcombe et al., has not been yet confirmed by 
other groups.   
 
2.5  SNARE proteins: coordinators of intracellular trafficking 
The SNARE (soluble-N-ethylmaleimide-sensitive-factor attachment protein receptor) 
protein family is known to be involved in intracellular vesicle budding, vesicular transport 
and visicle fusion 137-139. Until now, 38 members of the mammalian SNARE family have 
been reported (Table 1). Originally SNARE proteins were classified as v- (vesicle-
associated) or t- (target-membrane) SNAREs, on the basis of their locations and functional 
roles in a typical vesicle-membrane fusion process. This terminology was challenged by 
the fact that it is not always clear which side is the vesicle or the cognate target membrane 
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as fusion events often occur also between two vesicles. An alternative structure-based 
classification has now been suggested based on the following findings. Cognate SNARE 
proteins form a four-helix bundle complexe, composing of 16 β-sheet layers. At the layer 0 
there are four highly conserved residues ⎯ one arginine (R), three glutamine (Q) ⎯ 
contributed by the four SNARE motifs, respectively 138. On the basis of the central 
functional residue in their SNARE motif, the family is divided into R- (mostly 
corrsponding to v-SNAREs) and Q-SNAREs (mostly corresponding to t-SNAREs). Q-
SNARE proteins are further subclassified into Qa-, Qb-, Qc- and Qb,c-SNAREs, 
depending on the relative position of the conserved glutamine in the layer 0. Normally one 
SNARE protein contributes only one SNARE motif, whereas Qb,c-SNARE proteins 
contain two SNARE motifs. A functional four-helix bundle SNARE complexes require one 
R-SNARE and three Q-SNAREs to form R-Qa-Qb-Qc or R-Qa-Qb,c configurations139-140.   
 
 
 
Table 1. Members of SNARE family 141.  
 
The functions of SNARE proteins in T cells are only beginning to be elucidated. Das et al. 
showed that the Q-SNARE proteins syntaxin 4 and SNAP23 are clustered at the IS of 
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Jurkat T cells, and inactivation of VAMP2 and VAMP3 with tetanus toxin notably reduced 
the delivery and enrichment of TCR at the IS 106. This indicates that SNARE proteins may 
play important roles at the immunological synapse and VAMP2 and/or VAMP3 are 
involved in TCR transport and enrichment at the IS.  
Immune disorders induced by deficiencies of SNARE proteins and SNARE-regulatory 
proteins in humans and mouse models provide additional evidences of SNARE functions 
in CTLs. The lack of syntaxin 11 has been linked to the life-threatening familial 
hemophagocytic lymphohistiocytosis (FHL) type 4, in which CTLs and NK cells are 
incapable of releasing cytotoxic proteins from lytic granules to eliminate pathogen-infected 
cells 142-144.  This suggests that syntaxin 11 is essential for lytic granule exocytosis. In 
addition, mutations in the Munc13-4 or Rab27a gene, two SNARE-regulatory proteins, 
cause defects in lytic granule release, accounting for severe immune disorders 145-146.  
 
2.6  Disorders of human immunity: when killers cannot kill 
Several naturally occurring mutants of the granule-dependent cytotoxicity pathway have 
been described in humans and mice. Their molecular basis has been recently identified, 
which provides new insights into our understanding of the lytic granule-mediated 
cytotoxicity process. All of these disorders listed in Table 2 result in a specific condition 
termed hemophagocytic syndrome, which is known as hemophagocytic lymphohistio-
cytosis (HLH) in humans 147. HLH is characterized by unremitting CD8+ T cell 
proliferation, activation and infiltration of visceral organs combined with macrophage 
activation (hemophagocytosis), and in the deleterious secretion of multiple cytokines 
including interferon-γ, interleukin 1 (IL-1), IL-6, IL-18 and tumour necrosis factor α 148.    
 
2. Introduction 
____________________________________________________________________________________________________________ 
 
 
 19
 
 
Table 2. Genetic diseases that cause the hemophagocytic syndrome (HLH) 147.  
 
The X-linked proliferative syndrome (XLP) is a complex disease caused by mutations of 
the SH2DIA gene, which encodes SLAM-associated protein (SAP), a 17 kd protein mostly 
expressed in T, natural killer (NK) and natural killer T (NKT) lymphocytes. Absence or 
dysfunction of SAP results in fulminant infectious mononucleosis (a severe form of HLH) 
in 60% of the cases upon encounter of the Epstein-Barr virus (EBV), to lymphomas in 20–
30% of the cases, and to hypogammaglobulinemia in 30% of the cases, as well as to other 
less frequent manifestations 149-150. 
The Hermansky Pudlak syndrome (HPS) is a group of genetic diseases, associated with 
partial albinism and bleeding disorders 151-152. Mutations in 7 genes in humans and 16 in 
mice have been documented to be involved in HPS 153. HPS II is caused by mutations in 
the β subunit of the AP-3 (adaptor protein-3) 154-155. AP-3 is reported to be involved in 
sorting proteins from early endosomes to lysosomes 156-158. It has been shown that CTLs 
from HPS II patients fail to polarize lytic granules to the IS, whereas the MTOC polarizes 
normally 154. It has thus been postulated that AP-3 is necessary for sorting a yet 
unidentified protein required for lytic granule motility 147.  
Griscelli syndrome (GS), a rare autosomal recessive disorder, results in pigmentary 
dilution of the skin and the hair, the presence of large clumps of pigment in hair shafts and 
an uncontrolled T-lymphocyte and macrophage activation syndrome (known as 
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haemophagocytic syndrome, HS) 159-160. The CTLs, derived from GS patients as well as 
from the GS murine counterpart, ashen mice, display defective lytic granule-mediated 
cytotoxicity 146,161. Biallelic mutations in the gene encoding Rab27a ― a ubiquitously 
expressed small GTP-binding GTPase protein ― are responsible for GS II and the ashen 
phenotype 146,161. Rab27a-defective CTLs are unable to release lytic granules, although 
polarization is preserved. Using electron microscopy it has been shown that lytic granules 
can still accumulate at the IS, but fail to dock at the plasma membrane 146. At present it is 
not known which interacting partner(s) is (are) involved in Rab27a-mediated lytic granule 
docking at the plasma membrane.  
Familial hemophagocytosis lymphohistiocytosis (FHL) is characterized by an early onset 
HLH and defective cytolytic activity 162. Biallelic mutations of UNC13D encoding 
Munc13-4 were found in FHL type III patients. In Munc13-4 deficient CTLs lytic granules 
can polarize to the IS and dock at the plasma membrane, but fail to undergo exocytosis 145. 
Munc13-4 is a member of the Munc13 family, which is crucial for Ca2+-triggered 
exocytosis at neuronal synapses 163. It has been proposed that Munc13-4 mediates lytic 
granule fusion with the plasma membrane at the IS 147.  
In another variant of FHL (FHL4) observed in the Turkish and Kurdish population, a 
genetic deficiency in syntaxin-11 has been described 144. Syntaxin 11 was found to be 
enriched in tissues of the immune system including thymus, spleen and lymph nodes 164. It 
localizes in late endosomes, intermediate compart-ments and trans-golgi network 164-165. 
Although the precise functions of syntaxin-11 in lytic granule exocytosis are still obscure, 
it is certainly possible that syntaxin-11 is involved in SNARE-mediated fusion of lytic 
granules with plasma membrane.  
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Perforin deficiencies account for FHL2, which is responsible for 30–40% of all FHL 
conditions 44. Several different mutations have been characterized that lead to an absence 
or a defective cleavage of perforin, which is required for its function 166-167. This result 
stresses the indispensable key role of perforin in lytic granule-mediated cell death.  
 
2.7  Goals  
As described above, TCR recycling is important for TCR enrichment at the IS and for 
many of the down stream signaling culminating in T cell activation. But most of the 
recycling TCR enriched at the IS are not incorporated into the plasma membrane, in other 
words, they are not at the position to trigger downstream signaling cascades. In addition, as 
lateral movement of TCR within the plasma membrane can also contribute to TCR 
enrichment at the IS, it is not necessary to relocate recycling TCR to the IS for maintaining 
down stream signaling. However, if TCR recycling is blocked, T-cell function is 
drastically impaired. If re-localization of recycling TCR to the IS is not for triggering or 
maintaining downstream signals, what exactly are the functions of recycling TCR at the IS? 
Secretion of lytic granules at the IS only is pivotal to restrain CTL-induced cell death to the 
desirable target cells, but not bystander cells. Stinchcombe et al. suggest that the MTOC is 
involved in delivery of lytic granules to the IS. Many studies in genetic mutations, which 
lead to severe immune disorders, also show hints of how lytic granule release at the IS is 
regulated. Yet the detailed mechanism of how lytic granules accumulate preferentially at 
the IS is not completely elucidated. Although TCR enrichment and lytic granule 
accumulation at the IS are two prominent features of IS maturation, no evidence has been 
ever shown that these events are linked in any way.  
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Therefore the goals in this study are focused on:  
1. What is the functional importance of TCR recycling to the IS in CTLs? 
2. Are LG and TCR accumulation at the IS linked or independent of each other? 
3. Is the MTOC translocation the only mechanism to control lytic granule accumulation at 
the IS? 
4. Which SNARE protein(s) play(s) important role(s) in lytic granule accumulation and 
release at the IS? 
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3. Materials and methods 
3.1   Reagents 
All chemicals not specifically mentioned were from Sigma (highest grade). The reagents 
used in our experiments include: Alexa488-labeled anti-CD3 mAb (UCHT1, 300415, 
Biolegend), Alexa647-labeled anti-CD3 mAb (UCHT1, 300416, Biolegend), Alexa647-
labeled anti-perforin mAb (dG9, 308110, Biolegend), FITC-labeled anti-perforin mAb 
(dG9, 21146093S, ImmunoTools), Alexa568 goat anti-rabbit secondary Ab (A-11031, 
Invitrogen) and Alexa568 goat anti-mouse secondary Ab (A-11011, Invitrogen), rabbit 
polyclonal Vti1b antibody (164002, Synaptic Systems), anti-Vti1b mAb (611405, BD 
Biosciences), anti-human Adaptin delta mAb (611328, BD Biosciences), Alexa488-labeled 
Transferrin (T13342, Invitrogen), anti-γ-tubulin (T5192, Sigma). For TIRF microscopy, 
the antibodies against human CD3 (BB11, Euroclone) and CD28 (555725, BD Bioscience) 
were used for coating the coverslips.  
 
3.2   Cells  
3.2.1 PBL isolation 
Human peripheral blood lymphocytes (PBL) were obtained from healthy donors as 
described previously 168. Research carried out for this study with human material has been 
approved by the local ethics committee. The leucocyte reduction chambers (LRS chamber) 
were used for PBL isolation. The LRS chambers were kindly provided by the 
Blutspendedienst der Universitätskliniken des Saarlandes der Abteilung für klinische 
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Hämostaseololgie und Transfusionsmedizin. The information of the blood donors was 
obtained the next day after PBL preparation, including the gender, the age, the blood group, 
HIV and hepatitis positive or negative. The procedure of PBL isoloation is as follows: 
 
• Transfer 15-17 ml lymphocate isolation buffer (LSM1077 Lymphocyte, J15-004, 
PAA Laboratories) in a Leucosep® filtered tube (227290, Greiner) and centrifuge at 
1000 × g for 30 seconds at room temperature.  
• Clamp the LRS chamber on a flask support stand and cut the ends of the chamber 
with sterilized scissors. Perfuse the chamber with HBSS (Hank’s BSS, H15-009, 
PAA Laboratories) into the prepared Leucosep® tube up to 50 ml.  
• Centrifuge the tube at 450 × g for 30 min (Brake: 0, Accelaration: 1) at room 
temperature.  
• Transfer the ring like section with leucocytes in a new 50 ml Falcon-tube and fill 
HBSS up to 50 ml. 
• Centrifuge the tube at 250 × g for 15 min at room temperature. 
• Remove the supernatant and resuspend the pellet in 1-3 ml lysis buffer (155 mM 
NH4Cl, 10 mM KHCO3, 13 mM EDTA, pH 7.3) to lyse the erythrocytes.  
• Keep the cells in the lysis buffer for 1 minute and then immediately fill HBSS up to 
50 ml.  
• Centrifuge the tube at 130 × g for 10 min at room temperature. 
• Remove the supernatant and resuspend the pellet in 20 ml cold 0.5 % BSA/PBS. 
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3.2.2 CD8+ T cell isolation 
To get SEA (Staphylococcal Enterotoxin A)-specific CTLs, purified lymphocytes were 
stimulated with SEA (5 µg/ml, S-9399, Sigma) in AIMV medium (12055, Invitrogen) at a 
density of 1 × 108 cells/ml, at 37°C for 1 hr. After that, stimulated PBLs were re-suspended 
at a density of 2 × 106 cells/ml in AIMV medium supplemented with 10% FCS and 100 
U/ml of recombinant human IL-2 (PHC0021, Biosource). After 5 days, SEA-specific CTLs 
were positively isolated using a Dynal® CD8 positive isolation kit (113.33D, Invitrogen). 
Purified SEA-specific CTLs were then maintained in AIMV medium supplemented with 
10 % FCS and 100 U/ml of recombinant human IL-2. The CTLs from day 2 to day 3 after 
positive isolation were used for experiments.  
For TIRF microscopy and live cell imaging, naïve CD8+ T cells were isolated from PBLs 
using a CD8 negative isolation kit (Dynabeads® Untouched™ Human CD8 T Cells, 
113.48D, Invitrogen) and one day after isolation the CD8+ T cells were stimulated with 
Dynabeads® Human T-Activator CD3/CD28 (111.31D, Invitrogen).  
3.2.3 Cell culture 
Naïve CD8+ T cells were maintained in at a density of 3 × 106 cells/ml in AIMV medium 
supplemented with 10% FCS (10270-106, Invitrogen) and CTLs were maintained at a 
density of 1 × 106 to 4 × 106 cells/ml in AIMV medium supplemented with 10% FCS and 
100 U/ml of recombinant human IL-2.  
Raji cells (CCL-86™, ATCC) were maintained in RPMI 1640 medium (21875, Invitrogen) 
supplemented with 10% FCS.  
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3.3   Electroporation of CD8+ T cells 
For SEA-specific CTLs, 1 day after positive isolation cells (5 × 106 to 6 × 106  cells for one 
transfection) were collected and washed once with pre-warmed 0.5% BSA/PBS by low 
speed centrifugation (100 × g, 8 min). AIMV medium was plated in a12-well plate and 
pre-incubated in the incubator for 30 min before transfection to equilibrate CO2. The cells 
were electroporated with siRNA using the Human T cell nucleofector kit (VPA-1002, 
Lonza) with the program T-023 in Amaxa Nucleofacter™ II. Afterwards the cells were 
maintained in CO2-preequilibrated AIMV medium (containing 10% FCS, 1.5 ml for one 
transfection). 12 hours after electroporation, the dead cells were removed by low speed 
centrifugation (100 × g, 8 min) and fresh AIMV medium (containing 10% FCS and 
50U/ml IL-2, 3.5 ml for one transfection) was given to the cells. 36 hours after 
electroporation the cells were used for experiments. 
For CD3/CD28 bead-stimulated CD8+ T cells, 3 days after stimulation the beads were 
removed by the magnet. Cells (5 × 106 cells for one transfection) were collected and 
washed once with pre-warmed 0.5% BSA/PBS by low speed centrifugation (100 × g, 8 
min). The cells were then electroporated with 1.5 µg of perforin-mCherry (or siRNA and 
perforin-mCherry) using the Human T cell nucleofector kit with the program T-023 in 
Amaxa Nucleofacter™ II. Afterwards the cells were maintained in CO2-preequilibrated 
AIMV medium (containing 10% FCS, 1.5 ml for one transfection). 6 hours after 
electroporation, the dead cells were removed by low speed centrifugation (100 × g, 8 min) 
and fresh AIMV medium (containing 10% FCS, 2 ml for one transfection) was given to the 
cells. 24 to 30 hours after electroporation the cells were used for experiments. 
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3.4   Construction of cDNA 
Perforin was amplified from human cDNA with primers 5’ TAT ATA AGA TCT CCA 
CCA TGG CAG CCC GTG TGC TCC and 5’ TAT ATA TAC CGG TGG CCA CAC 
GGC CCC ACT CCG G to add Bgl2 and Age1 restriction sites at each end. The mCherry 
construct was obtained as a gift from Roger Tsien. After Age1 and Bgl2 restriction 
digestion, perforin was ligated to mCherry at its C-terminus and then purified. 
 
3.5   Labeling recycling TCR in live cells 
To specifically label endocytosed TCR and plasma membrane TCR, CTLs were first 
incubated with Alexa488-labeled anti-CD3 mAb in AIMV medium at 37 °C for 30 min. The 
cells were then put on ice and the remaining surface labeling was removed by washing the 
cells twice for 1 min with ice-cold acid medium (RPMI [Invitrogen], 25 mM sodium 
acetate [pH 2]), followed by neutralization with RPMI (pH 10). After that the cells were 
incubated with Alexa647-labeled anti-CD3 mAb in AIMV medium on ice for 1.5 hr to label 
plasma membrane TCR. Same procedure described above was followed to make the 
conjugation of CTLs to target cells. 
 
3.6   Immunofluorescence 
Raji cells were pulsed with 10 µg/ml of SEA in AIMV medium (10% FCS) at 37°C for 30 
min. CTLs were incubated with Alexa488-labeled anti-CD3 mAb at 37°C for 30 min to 
label rTCR. After that CTLs and SEA-pulsed Raji cells were harvested and washed once 
with fresh AIMV medium by centrifugation at 200 × g for 5 min. The supernatant was then 
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removed and cells were resuspended at a density of 2 × 107 cells/ml in AIMV medium. 
CTLs and Raji cells were mixed at a ratio of 1:1 and this cell suspension were incubated at 
37 °C for 5 min. After that the cell suspension was diluted to a density of 4 × 106 cells/ml 
and plated onto poly-ornithine pre-coated glass coverslips and incubated at 37 °C for the 
time specified in the figure legends. Samples were then fixed with ice-cold 4% of 
paraformaldehyde for 20 min and processed for immunofluorescence as follows: 
 
• Wash the samples once with 0.1M Glycine (in PBS) for 3 min; 
• Remove glycine buffer and incubate the samples with 0.1% Triton/PBS buffer for 
15 min to permeabilize the cells; 
• The samples were then incubated with blocking buffer (2% BSA, 0.1% Triton/PBS) 
for 15 min to block the unspecific binding sites in the samples; 
• Afterwards the primary antibody (1:50 to 1:500 in blocking buffer, depending on 
the antibody) was given to the samples for 1.5 hours at room temperature or 
overnight at 4 °C; then the primary antibody was removed and the samples were 
washed with 0.1% Triton/PBS for 3 times; 
• Afterwards the secondory antibody (1:2000 in blocking buffer) was given to the 
samples for 45 min at room temperature; then the antibody was removed and the 
samples were washed with 0.1% Triton/PBS twice and with PBS once; 
• The samples were carefully mounted in the mounting medium. 
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3.7   Confocal microscopy 
Confocal microscopy was carried out on a Nikon E600 using a 100× objective in the 
Department of Cell Biology (Prof. Peter Lipp). Serial confocal z-sections were taken at 0.2 
µm intervals for whole cell analysis. Normally 30 to 40 slices were taken for each cell 
which contained all the three-dimensional fluorescence information. Detectors were set to 
detect an optimal signal below the saturation limits. Image sets to be compared were 
acquired during the same session and using the same acquisition settings. Interaction 
between lytic granules and recycling TCR compartments was quantified through the z-
sections, meaning that both lateral and longitudinal interaction were taken into account. 
ImageJ 1.37v software was used to generate merged images and projections of confocal 
sections.  
 
3.8   Epifluorescence deconvolution microscopy and time-lapse imaging 
Human CTLs overexpressing perforin-mCherry were incubated with Alexa488-labeled anti-
CD3 mAb at 37 °C for 30 min. 4D fluorescence microscopy was performed with a Zeiss 
Cell Observer HS system with a 100× alpha Plan-Fluar Objective (N.A. 1.45) and an 
AxioCam MRm Rev. 3. The filter set was a Zeiss 62 HE tripleband with single excitation 
filters inside the fast-wavelength switching xenon burner DG-4 (Sutter Instruments). For 
fixed cells, images were acquired with binning 1 × 1 and a z-stepsize of 0.2 µm.  For time-
lapse imaging, to acquire the images as fast as possible, the cells were scanned with 
binning 3 × 3 and a z-stepsize of 1 µm. Iterative deconvolution was performed using a 
point spread function (PSF) calculated with the z-stack acquisition from a 170 nm 
fluorescent bead (Tetraspeck, Invitrogen). 
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3.9   Evanescent-wave imaging 
A TIRF setup as described 169 was used with the following additions: a solid-state laser 85 
YCA emitting at 561nm (Melles Griot), a dual-view camera splitter (Visitron) to separate 
the red and green channels, a Visichrome Monochromator (Visitron) to acquire images in 
epifluorescence. Human CTLs overexpressing perforin-mCherry were washed and allowed 
to settle for 2 min on anti-CD3/anti-CD28 antibody-coated coverslips. Cells were imaged 
for 30 min by TIRFM at 561 nm. To distinguish between secretion of LG and movement 
of granules from the plasma membrane inside the cell, we also recorded the cell in 
epifluorescence at 561 nm. Following each TIRF image, three images were acquired as 
epifluorescence stacks with a z-stepsize of 0.5µm, the first epifluorecence plane being at 
the same plane as that of TIRFM. For experiments with paired vesicles, cells were pre-
incubated with Alexa488-conjugated anti-CD3 mAb at 37 °C for 30 min and then were 
settled on anti-CD3/anti-CD28 antibody-coated coverslips as described above. Cells were 
imaged for 20 min by TIRFM at 488 and 561 nm. Since the granules never moved 1.0 µm 
above the TIRF plane and for faster imaging with two lasers, following each TIRF image, 
only two images were acquired in epifluorescence at 561 nm, one at the same plane as that 
of TIRFM and the second image at 0.75 µm above the TIRF plane. The acquisition speed 
was 1 Hz and the exposure time was 100 ms. 
 
3.10  Lytic granule accumulation analysis 
The analysis of lytic granule accumulation was performed with Metamorph version 6.3. 
The raw data stacks were first corrected for background and then a threshold value was set 
for every cell such that only the pixels above a given fluorescence intensity that mark the 
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lytic granules were selected. The value of the pixels defined as the threshold area was 
obtained for every frame of the time lapse movie for each individual cell. Due to 
difficulties in tracking every single vesicle for all the cells, a ratio was made between the 
threshold area and number of vesicles for a minimum of three frames for every cell. The 
area threshold was then divided by this ratio for all the time frames to get the number of 
vesicles for each frame. The average of the number of vesicles was then plotted against the 
time in seconds.  
 
3.11  Small interfering RNA (siRNA) 
All siRNA used in this study were modified by Qiagen as described by Mantei et al. 170. 
SEA-specific CTLs were transfected with modified siRNA designed to silence human 
vti1b (VTi1B_8_4479, Qiagen) using nucleofector kit (Lonza) according to the 
manufacturer’s instructions. A modified non-silencing siRNA (A3617/18S, Qiagen) was 
used as control. Fresh AIMV medium containing 50 U/ml recombinant human IL-2 was 
given to the cells 12 hours after transfection. The cells were then kept in culture for 
additional 24 hours before use. 
 
3.12  RealTime-PCR 
For Quantitative RealTime-PCR (qRT-PCR), total RNA was isolated using TRIzol® 
Reagent (15596018, Invitrogen) including 1 µl Glycogen (5 µg/µl, 10814-010, Invitrogen) 
according to the manufacturer’s protocol as follows: 
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• Harvest cells (1-1.5 × 106 cells for each sample) by centrifugation at 200 × g for 5 
minute and then add 800 µl TRIzol to the pellet; 
• Centrifuge at 12,000 × g, 10 min at room temperature; 
• Transfer the supernatant to a fresh eppendorf tube and incubate for 5 min at room 
temperature; 
• Add 0.2 ml of Chloroform and shake vigorously for about 15 seconds; 
• Leave the samples at room temperature for 2-3 min; 
• Centrifuge at 12,000 × g, 15 min at 4 °C; 
• Transfer the aqueous phase to a fresh tube and add 1 µl Glycogen (5 µg/µl); 
• Add 0.5 ml of Isopropanol and incubate for 10 min at room temperature; 
• Centrifuge at 12,000 × g, 10 min at 4 °C; 
• Remove the supernatant and add 1 ml of 75% Ethonol (in DEPC-treated H2O); 
• Centrifuge at 7,500 × g, 5 min at 4 °C; 
• Leave the RNA pellet dry at room temperature and then dissolve RNA in 10µl of 
DEPC-treated H2O; 
• Determine the concentration of RNA using 2% Agarose gel.  
 
0.8 µg total RNA was then reverse transcribed into cDNA by SuperScript™ II reverse 
trancriptase (18064-014, Invitrogen) including 1 µl RNaseOut, (10777-019, Invitrogen) 
and 1 µl oligo dT Primer (0.5 µg/µl, 18418-012, Invitrogen) following the manufacturer’s 
instruction. RealTime PCR was carried out in a MX3000 instrument from Stratagene. 1.0 
µl cDNA and 300 nM of each primer were set into PCR reactions (25 µl) using Quanti 
Tect SYBR green kit (204145, Qiagen). PCR conditions were: initial denaturation, 15 min, 
94 °C; 45 cycles: denaturation, 30 s, 94 °C; annealing, 45 s, 58 °C; elongation, 30 s, 72 °C 
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and finally a dissociation curve cycle (60 s, 95 °C; 30 s 55 °C; 30 s 95 °C). Primers were 
designed using Primer3 program 171 available at http://frodo.wi.mit.edu/. PCR fragments 
were confirmed by sequencing (MWG). 
 
3.13  Western blotting 
CTLs were collected 36 hours after siRNA transfection. The cells (1.5 × 107 cells for each 
sample) were collected and washed once with PBS before putting in SDS loading buffer 
containing 1% β-mercaptoethanol (50 µl for each sample). Afterwards the cells were 
disrupted and homogenized by sonication. The samples were then incubated at 95°C for 5 
min. Equivalent amounts of proteins were separated by 12% Tris-Glycine SDS-PAGE gels 
and transferred to nitrocellulose membrane using X-Cell II (Invitrogen). ECL reagent 
(34076, Pierce) was used for immunoblot detection.  
 
3.14  Cytotoxicity assay 
The CytoTox 96® Non-Radioactive Cytotoxicity Assay (G1780, Promega) was used to 
detect target lysis. SEA-specific CTLs were plated in 96-well plates in AIMV medium (5% 
FCS) with 1 × 104 SEA-pulsed Raji target cells in each well at various effector/target ratios 
(the experimental reactions). CTLs and SEA-pulsed Raji target cells were then incubated at 
37 °C for 4 hours and the Lactate dehydrogenase activity in the supernatant was measured. 
The cells were spinned down at 200 g for 4 min. 50 µl of supernatant from each well was 
transferred into a new black 96-well plate with clear flat-bottom (353948, BD Biosciences). 
The supernatant was incubated with the reaction substrate (50 µl for each well) for 30 min 
at room temperature. The reaction was ceased by adding the stop solution (50 µl for each 
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well). The absorbance was measured at 490 nm with the GENios-Pro plate reader 
(TECAN). Control reactions were set as follows:  
• Effector Cell Spontaneous LDH Release: Add effector cells at each concentration 
used in the experimental setup to wells containing AIMV medium (5% FCS). The 
final volume was adjusted to the same as in the experimental wells.  
• Target Cell Spontaneous LDH Release: Add target cells (1 × 104 in each well) to 
wells containing AIMV medium (5% FCS). The final volume was adjusted to the 
same as in the experimental wells. 
• Target Cell Maximum LDH Release:  Add target cells (1 × 104 in each well) to 
wells containing AIMV medium (5% FCS). The final volume was adjusted to the 
same as in the experimental wells. 45 min prior to harvesting the supernatants from 
experimental reactions, 10 µl of the Lysis Solution (10×) was added to each well.  
• Volume Correction Control: Add 10 µl of Lysis Solution (10×) to a triplicate set of 
wells containing 100 µl of AIMV medium (5% FCS). This control is used to 
correct for the volume increase caused by the addition of Lysis Solution (10×).  
• Culture Medium Background: Add 100 µl of AIMV medium (5% FCS) to a 
triplicate set of wells.  
Each experimental and control reaction was performed in triplicate. To calculate the results, 
we first substracted the average of absorbance values of the Culture Medium Background 
from all absorbance valules of experimental and control reactions. The volume change of 
the Target Cell Maximum LDH Release was then corrected by substracting the average of 
the Volume Correction Control. Use these corrected values in the following formula to 
compute percent cytotoxicity for each effector : target cell ratio.  
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% Cytotoxicity  = (Experimental – Effector Spontaneous – Target Spontaneous) / (Target 
Maximum – Target Spontaneous) × 100.  
 
3.15  Data analysis 
Data were analyzed using ImageJ 1.37v, Metamorph (Visitron), AxioVision (Zeiss), Igor 
Pro (Wavemetrics), Microsoft Excel (Microsoft) and SigmaPlot 8.0. All values are given 
as mean ± S.E.M if not mentioned otherwise. In case, data points were normally distributed, 
an unpaired two-sided student t-test was used. If normal distribution could not be 
confirmed, a non-parametric test (Mann-Whitney) was performed. P-values are stated in 
the figure legends. * P<0.05, ** P<0.01, *** P<0.005. 
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4. Results 
4.1   LG were tethered with rTCR 
4.1.1 Recycling TCR was not in the position to trigger downstream signaling 
Previous reports have shown that TCR recycling is essential for TCR enrichment at the IS 
after target cell recognition 104-106. It’s reasonable to assume that recycling TCR are 
involved in recruiting effecter molecules and triggering downstream signaling pathways. 
We first characterized the kinetics of the recycling TCR translocation to the the IS. We 
labelled recycling TCR by pre-incubation of Alexa488-conjugated anti-CD3 antibody with 
CTLs at 37°C for 30 minutes. Afterwards the antibody remaining on the cell surface was 
washed away, followed by labelling cell surface TCR with Alexa647-conjugated anti-CD3 
antibody. Then the CTLs were incubated with target cells ⎯ SEA-pulsed Raji cells ⎯ to 
form the CTL-target cell conjugates. Afterwards the CTL-target cell conjugates were fixed 
with ice-cold 4% of paraformaldehyde (PFA). We found that the TCR initially enriched at 
the IS were the plasma membrane TCR. Whereas, most of the recycling TCR unexpectedly 
approached the IS only at later time points, between 15 min and 30 min after target cell 
recognition (Fig. 1A). This result suggests that recycling TCR enrichment at the IS is not 
necessary to recruit effecter molecules to the IS and initiate downstream signalling 
pathways immediately after target cell recognition. 
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Figure 1. The initial TCR enrichment at the IS was not initiated by rTCR. (A) TCR on the surface 
initiates IS formation. Endocytosed TCR (TCR-endo, green) was labeled with Alexa488-labeled anti-CD3 
mAb. TCR remaining on the cell surface (TCR-Mem, red) was labeled by Alexa647-labeled anti-CD3 mAb. 
BF, bright field. (B) The recycling TCR (green) was labeled with Alexa488-labeled anti-CD3 mAb. Among 
the TCR accumulated at the IS, only some were incorporated into plasma membrane, which were labeled by 
Alexa568 secondary Ab under nonpermeabilizing conditions (red). Scale bars are 3 µm.   
 
To analyze whether recycling TCR were incorporated into the plasma membrane and could 
thus be involved in maintaining signaling, we examined the localization of recycling TCR 
at the IS with the following staining protocol using confocal microscopy. The recycling 
TCR were pre-labelled by of Alexa488-conjugated anti-CD3 antibody in live CTLs. To 
determine the recycling TCR incorporated into the plasma membrane, we stained the 
samples (30 minutes after contact) with Alexa568-conjugated secondary antibody without 
permeablizing the cells. We found that only a small fraction of the TCR, which were 
recycled to the IS, were incorporated into the plasma membrane (Fig. 1B), indicating that 
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recycling TCR may have other functions apart from triggering or maintaining downstream. 
This raises the question why there is a robust TCR enrichment at the IS, if most of 
receptors are not incorporated into the plasma membrane to trigger downstream signalling. 
To address this question we examined alternative functions of recycling TCR.  
 
4.1.2 Lytic granules were localized next to recycling TCR 
After CTLs recognize target cells, lytic granules are reorientated and accumulated at the IS. 
The transport, docking and release of lytic granule at the IS are required for effective target 
cell killing 9, while dysfunction of lytic granule release is associated with life-threatening 
familial or acquired hemophagocytic lymphohistiocytosis 172. Lytic granules and recycling 
TCR are located in distinct compartments and no evidence has been shown that there is a 
common mechanism to transport them to the IS. To explore whether the transport and/or 
accumulation of recycling TCR and lytic granules was linked in any way, we examined the 
localization of lytic granules and recycling TCR. We pre-incubated Alexa488-conjugated 
anti-CD3 antibodies with CTLs to label the recycling TCR. Then the CTLs were incubated 
with target cells to form the conjugates. Afterwards the CTL-target cell conjugates were 
fixed at various time points. Unexpectedly, we found that many lytic granules were 
paired/tethered with recycling TCR in both resting and activated CTLs (Fig. 2A).  
We subsequently examined the lytic granule/recycling TCR (LG/rTCR) pairing rate at 
different CTL states after target cell recognition. The analysis showed that in the resting 
state, the LG/rTCR pairing rate was already considerably high; during IS maturation, the 
LG/rTCR pairing rate was higher than 80% (Fig. 2B). This high level of compartment 
pairing suggests that recycling TCR play an important role in the function of lytic granules 
at the IS.  
 
4. Results 
____________________________________________________________________________________________________________ 
 
 
 39
 
 
 
Figure 2. LG are localized next to rTCR. (A) CTLs were pre-incubated with Alexa488-labeled anti-CD3 
mAb to label rTCR. Perforin was used as the LG marker. In both resting CTLs and CTLs in contact with 
target cells, LG (red) were next to rTCR (green). (B) The possibility of tethering LG with rTCR is high 
before and after IS formation. For resting, 5 min, 15 min and 30 min, 215, 170, 221 and 145 LG were 
analyzed. 
 
To exclude that lytic granules and recycling TCR were in fact colocalized but not 
paired/tethered, we performed two types of control experiments. Fig. 3A shows the 
staining of recycling TCR with Alexa647- and Alexa488-conjugated anti-CD3 antibodies.  
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Figure 3. Tethering of LG and rTCR is specific. (A) Confocal analysis of TCR labeled with Alexa488- and 
Alexa647-labeled anti-CD3 mAb. (B) Pairing is distinct from co-localization. rTCR were labeled with 
Alexa488-labeled anti-CD3 mAb in a and d, as well as Alexa647-labeled anti-CD3 mAb in a and c. LG were 
labeled with Alexa647-labeled anti-perforin mAb in b and d, as well as FITC-labeled anti-perforin mAb in b 
and c. Images were taken with the Zeiss Cell Observer and deconvoluted with the corresponding PSF. (C) 
Localization of lytic granules relative to endocytosed TfR compartments. Prior to conjugation with SEA-
pulsed Raji cells, CTLs were incubated with Alexa488-Tf at 37 °C for 30 min to label the endocytosed TfR. 
LG were labeled with Alexa647-labeled anti-perforin mAb. Scale bars are 3µm. (D) The rate of lytic granule 
pairing with endocytosed TfR and rTCR. 
 
In contrast to the juxtaposition of lytic granules and rTCR shown in Figure 1B, a perfect 
co-localization of both anti-CD3 antibodies was observed by confocal microscopy as 
expected (Fig. 3A) because both antibodies stain the same protein and are thus localized in 
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the same compartments. Co-localization of proteins can therefore be clearly distinguished 
from proteins that are juxtapositioned.  
Moreover, we verified colocalization versus pairing using epifluorescence deconvolution 
microscopy. Four combinations of staining of lytic granules and recycling TCR were 
examined: (a) Alexa647- and Alexa488-conjugated anti-CD3 antibodies, (b) Alexa647- and 
FITC-conjugated anti-perforin antibodies, (c) Alexa647-conjugated anti-CD3 and FITC-
conjugated anti-perforin antibodies, (d) Alexa488-conjugated anti-CD3 and Alexa647-
conjugated anti-perforin antibodies (Fig. 3B). As expected, the control double staining of 
recycling TCR or lytic granules showed a clear colocalization (Fig. 3B a, b). However, the 
two separate staining conditions of lytic granules and recycling TCR (Fig. 3B c, d) showed 
no colocalization but some LG/rTCR pairs. This demonstrates that lytic granules and 
recycling TCR can form pairs in CTLs. Given the fact that more than 60% lytic granules 
are paired with recycling TCR in resting CTLs and that this number increases during IS 
maturation, we propose that the pairing of lytic granules and recycling TCR is important 
for the function of lytic granules.  
To prove the specificity of pairing between eTCR and LG, we compared the localization of 
LG and the endocytosed transferrin receptor as a control. Transferrin is recycled through 
the constitutive recycling pathway 173-174. Using Alexa488-conjugated transferrin to label 
recycling transferrin receptors (TfR), we observed only infrequent pairing between lytic 
granules and the endocytosed TfR (Fig. 3C). This pairing was on average less than 30% in 
contrast to the 80% pairing between lytic granules and rTCR (Fig. 3D). We conclude that 
lytic granules pair with recycling TCR compartments and not with constitutively recycling 
endosomes. 
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4.1.3 Paired lytic granules are preferentially accumulated at the IS 
Since the accumulation and release of lytic granules at the IS are the two critical steps for 
executing lytic granule function in CTLs, we first examined whether lytic granule 
accumulation at the IS is affected by LG/rTCR pairing. We quantified the localization of 
single and paired lytic granules in CTLs at various time points. As shown in Fig. 4 left 
image, we divided the CTL evenly in diameter into three parts and defined the part closest 
to the IS as in proximity to the IS (P). If we assume CTLs are sphere-shaped, the volume of 
P part should be 25.9 % of the total volume of the cell according to the sphere-volume 
formula. In other words, if granules are randomly distributed in cells, there should be about 
25.9 % of the granules in the P part. In resting CTLs the distribution of single and paired 
lytic granules was very close to this number, suggesting that there was no preferential 
accumulation of single or paired lytic granules in the resting CTLs (Fig. 4). However, upon 
time after CTLs contacted with target cells, the percentage of paired lytic granules in 
proximity to the IS was significantly enhanced, whereas not much change occurred 
regarding the localization of single lytic granules (Fig. 4). This data indicates that the 
probability of lytic granule accumulation at the IS is increased by pairing lytic granules 
with recycling TCR.  
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Figure 4. Paired LG were preferentially accumulated at the IS. LG in proximity to the IS were analyzed 
at various time points. Recycling TCR was labeled with Alexa488-conjugated anti-CD3 mAb (green). LG was 
labeled with Alexa647-conjugated anti-perforin mAb (red). The CTL was divided evenly in diameter into 
three parts as shown above. The part closest to the IS was defined as in proximity to the IS.  (from lower 
dashed line to the lower solid line). Rest., resting CTLs. We analyzed 76, 37, 47 and 33 single LG and 159, 
115, 134 and 157 paired LG for resting, 5 min, 15 min and 30 min, respectively.  
 
4.2   Lytic granules are accumulated at the IS by tethering with rTCR 
4.2.1 Paired lytic granules have longer dwell time at the IS 
The data described above were obtained from the fixed cells, which provided important 
information about granule movement, but it lacked the information about granule 
movement in real-time. To visualize the kinetics of vesicle movement, we designed 
experiments in living CTLs. We used fast 4D fluorescence microscopy to visualize 
movements of lytic granules and recycling TCR in live cells. To label lytic granules in 
living cells, CTLs were transfected with mCherry-tagged perforin. The next day after the 
electroporation, CTLs were pre-incubated with Alexa488-conjugated anti-CD3 antibody at 
37°C for 30 minutes to label recycling TCR. Subsequently the CTLs were incubated with 
SEA-pulsed Raji cells. The time-lapse recordings were started right after Raji cells were 
added.  
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In all CTLs we observed LG/rTCR pairs that were transported to the IS (Fig. 5A). After 
LG/rTCR pairs reached the IS, more than 80% of these LG/rTCR pairs remained at the IS 
for longer than 30 seconds. In some CTLs single lytic granules were also transported to the 
IS. However, 30 seconds after approaching the IS only 20% of these single lytic granules 
still remained at the IS (Fig. 5B). These data show that lytic granules and recycling TCR 
can be transported together to the IS as LG/rTCR pairs and that tethering with recycling 
TCR increases the dwell time of lytic granules at the IS. 
 
 
Figure 5. Tethered LG and rTCR were transported to the IS. CTLs overexpressing perforin-mCherry 
were incubated with Alexa488-labeled anti-CD3 mAb to label rTCR. A time-lapse recording was made every 
5 seconds with a Zeiss Cell Observer HS system. One exemplary trace of tethered LG and rTCR moving to 
the IS is shown in (A). After approaching the IS, the percentage of single and paired LG which stayed at the 
IS longer than 30 s is shown in (B), 26 cells were analyzed. 
 
 
To analyze the dwell times of lytic granules at the IS in more detail, we used the total 
internal reflection fluorescence (TIRF) microscopy technique, which allows exclusive 
visualization of granules within about 200 nm of the IS. To apply TIRF microscopy, a 
functional IS was formed between CTLs and anti-CD3/anti-CD28 antibody-coated glass 
coverslips 169.  
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Figure 6.  Paired LG have longer dwell times at the IS. LG (red) were marked with perforin-mCherry and 
rTCR (green) were labeled by pre-incubation the CTLs with Alexa488-labeled anti-CD3 mAb. Then LG and 
rTCR were visualized by TIRF microscopy. Examplary traces of LG paired with rTCR (A) or without rTCR 
(B) are shown. Note the different time scale reflecting the dwell time of the LG at the IS. (C) Quantification 
of the dwell time of individual LG at the IS. Single LG, n = 12; Paired LG, n = 19. Scale bars are 3 µm.  
 
As described for the 4D-time-lapse imaging, we labeled the lytic granules and recycling 
TCR with overexpressing mCherry-Perforin and Alexa488-conjugated anti-CD3 antibody, 
respectively. We found that most lytic granules reached the IS being paired with recycling 
TCR, and paired lytic granules resided at the IS much longer than single lytic granules (Fig. 
6A, B). On average, the dwell times of paired lytic granules were ten times longer than 
dwell times of single lytic granules (Fig. 6C). This finding further supports the hypothesis 
that tethering with recycling TCR is required for stabilizing/docking lytic granules at the IS. 
As a consequence, we predict that lytic granule release should be increased accordingly.  
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4.2.2 Paired lytic granules were secreted preferentially over single lytic granules 
In order to determine the influence of LG/rTCR pairing on vesicle release, we established 
an assay to analyze exocytosis of lytic granules in CTLs. Fig. 7A shows an example of 
secreted lytic granules. To confirm that a lytic granule was indeed secreted rather than 
simply having moved away from the TIRF plane, three consecutive epi-fluorescence 
images were acquired after every TIRF image, in order to determine vesicle movement 
away from the membrane back into the cytosol. The image series were taken every 1 
second for 20 minutes. If a granule disappeared from the TIRF plane and was also not 
found in the epi-fluorescence images, it had to be secreted (Fig. 7A). In contrast, if a 
granule disappeared in the TIRF plane, but was still seen in the epi-fluorescience images, it 
indicates that this granule has just moved away from the interface and back into the cytosol 
(Fig. 7B).  
Using this assay, we found that the average dwell times of the secreted lytic granules were 
drastically increased compared with the dwell times of non-secreted lytic granules (Fig. 
7C). This also implies that it is necessary for lytic granules to reside at the IS for a notably 
long time in order to prime and/or dock at the plasma membrane before undergoing the 
fusion process.  
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Figure 7. Distinguishing secretion from movement back into the cytosol. (A) TIRF and epifluorescence 
images taken at planes 0, 0.5 and 1.0 µm above the TIRF plane, before and after secretion. The LG (marked 
by an arrow), which was secreted, was neither present in the TIRF image nor in the epifluorescence stack 
images in the After panel. (B) A LG moved away from the TIRF plane. In the After panel the LG was not 
seen in the TIRF image, but was still visible in the epifluorescence images. Scale bars are 3 µm. (C) Dwell 
times of nonsecreted (Nonsec. n = 20) and secreted LG (Sec. n = 14).  
 
Next, we used this assay to examine the release of paired and single lytic granules. Fig. 8A 
shows the release of a paired lytic granule. On average, 88% of the released lytic granules 
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were paired (Fig. 8B). Furthermore, within the first 7 minutes after IS formation, all 
secreted lytic granules were paired with recycling TCR compartments. Given the results 
presented in Figs. 6-8 (that both secreted lytic granules and paired lytic granules have long 
dwell times and additionally paired lytic granules were secreted preferentially over single 
lytic granules), we conclude that pairing with recycling TCR stabilizes lytic granules at the 
IS and thus increases the probability of lytic granule release.  
 
 
 
Figure 8. Secretion of the LG paired with rTCR. (A) LG (red) were marked with perforin-mCherry and 
rTCR (green) were labeled by pre-incubation the CTLs with Alexa488-labeled anti-CD3 mAb. Then LG and 
rTCR were visualized by TIRF microscopy. Three consecutive epi-fluorescence images above TIRF plane 
were taken to make sure that the granule was secreted other than moving away from TIRF plane. The 
secreted paired LG is pointed with an open arrowhead. Scale bar is 3 µm. (B) Analysis of the relative 
proportion of single and paired LG release at the IS. 20 released vesicles were analyzed. 
 
4.2.3 The Golgi apparatus is involved in LG/rTCR pairing and plays a key role 
in LG/rTCR transport to the IS 
The question we ask next is where the pairing of lytic granules and rTCR takes place. It 
has been reported that the Golgi apparatus plays a pivotal role in TCR recycling 105 as well 
as in lysosomal protein processing and sorting 175. In the Golgi apparatus ― the harbor for 
protein sorting and transportation ― there are good chances for the lytic granules to meet 
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the recycling TCR. Therefore we examined the location of LG/rTCR pairs and the Golgi 
apparatus. We found that some LG/rTCR pairs did co-localize with the Golgi apparatus, 
but many of LG/rTCR pairs did not (Fig. 9). There are two explanations for this 
observation: either lytic granules pair with recycling TCR in the Golgi apparatus which are 
then rapidly transported elsewhere, or this pairing may take place not only in the Golgi 
apparatus but also elsewhere in CTLs.   
 
 
 
Figure 9. Paired LG are not colocalized with the Golgi marker. LG was labeled with Alexa647-conjugated 
perforin mAb. TCR was stained with Alexa488-conjugated CD3 mAb. GM130 was used as the marker for the 
Golgi apparatus. The merged images are shown in the lower panel. The LG/rTCR pair colocalized with 
GM130 is enlarged in the insertion. The other LG/rTCR pairs are highlighted by the arrowheads. The scale 
bar is 3 µm.  
 
To further analyze the function of the Golgi apparatus for LG/rTCR pairing, we used 
brefeldin A (BFA) to block functions of Golgi apparatus, by inhibiting the activation of 
Arf1 by its GEFs in vivo 176. CTLs were pre-treated with BFA for 30 minutes before 
forming the conjugates with target cells. We found that the pairing rate of lytic granules 
was reduced when the Golgi apparatus was disassembled by BFA (Fig. 10A and B).  
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Figure10. Inhibition of TCR recycling by BFA abolished accumulation of paired LG. (A) CTLs were 
treated with DMSO or BFA for 30 min at 37°C. LG (red) were marked with Alexa647-conjugated perforin 
mAb and rTCR (green) were labeled by pre-incubation CTLs with Alexa488-conjugated anti-CD3 mAb. After 
30 min incubation at 37 °C the CTL-target conjugates were fixed with ice-cold 4% PFA. A single plane from 
the stack is shown in the left panel (Confocal). The projection of the whole stack is shown in the middle 
panel (Projection). Scale bars are 3 µm. (B) The pairing rate of LG was reduced in BFA-treated CTLs. (C) 
The accumulation of LG at the IS was abolished by BFA treatment. Resting CTLs were taken as the control 
for the CTLs conjugated with SEA-pulsed Raji cells for 30 min. (D) The accumulation of paired LG at the IS 
was abolished by BFA treatment. In proximity to the IS was defined as in Fig. 4.  
 
Moreover, lytic granules accumulation at the IS was substantially inhibited in the presence 
of BFA (Fig. 10C). In particular, the accumulation of paired lytic granules at the IS was 
completely abolished by BFA treatment, whereas there was no change in single lytic 
granule distribution (Fig. 10D). These results suggest that the Golgi apparatus is involved 
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in LG/rTCR pairing; more importantly, the Golgi apparatus plays a key role in the 
transport of paired lytic granules to the IS and consequently regulates lytic granule 
accumulation at the IS. 
4.3  Vti1b co-localized with paired LG and enhances the possibility for 
vesicle pairing 
4.3.1 Analyzing the co-localization of SNARE proteins with lytic granules and 
recycling TCR  
The next question to be addressed is which protein(s) is (are) responsible for LG/rTCR 
pairing. SNARE proteins are known to be the key players in intracellular vesicle budding, 
vesicular transport and vesicle fusion 137-139. We therefore examined the localization of 
SNARE proteins and lytic granules in parallel with TCR. We screened all SNARE proteins 
against commercially available antibodies at the time. Some examples are shown in Fig. 10. 
From all the SNARE proteins examined, we found that the Qb-SNARE protein Vti1b co-
localized very well with lytic granules and with recycling TCR. In addition, Vti1b also 
accumulated at the IS after target cell recognition (Fig. 11). Some SNARE proteins 
examined were also enriched at the IS, such as Qa-SNAREs syntaxin 4 and syntaxin 16, 
Qb-SNARE Vti1a and Qc-SNARE syntaxin 6. However they didn’t show good co-
localization either with lytic graules or recycling TCR (Fig. 11).  
To further verify the colocalization of Vti1b with both lytic granules and recycling TCR, 
we investigated various time points after CTLs contact with target cells. We again found 
that at all the time points Vti1b co-localized very well with lytic granules as well as 
recycling TCR. Furthermore, Vti1b reorientation to the IS along with lytic granules and 
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recycling TCR during IS maturation was again confirmed  (Fig. 12 A and B). Given these 
results, we formulated the following hypothesis: 
1. Vti1b may be involved in accumulation of lytic granules and recycling TCR at the IS 
2. Vti1b may play a role in LG/rTCR pairing 
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Figure 11. Locolization of SNARE proteins, TCR and LG in CTLs. CTLs were incubated with SEA-
pulsed Raji cells at 37 °C for 30 min and then were fixed with 4% ice-cold PFA. TCR were stained with 
Alexa488-conjugated anti-CD3 mAb. LG were labeled with Alexa647-conjugated anti-perforin mAb. Scale 
bars are 3 µl.   
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Figure 12. Vti1b co-localizes with LG as well as rTCR. CTLs were incubated with SEA-pulsed Raji cells 
and fixed with ice-cold 4% PFA at different time points. LG were marked with Alexa647-conjugated perforin 
mAb (A) and rTCR were labeled by pre-incubation the CTLs with Alexa488-conjugated anti-CD3 mAb (B). 
Scale bars are 3 µm. 
 
 
4.3.2 Vti1b co-localizes with paired lytic granules 
To verify localization of Vti1b and LG/rTCR pairs, we performed a triple staining for 
Vti1b, recycling TCR and lytic granules in resting CTLs. We found that Vti1b co-localized 
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very well with LG/rTCR pairs (Fig. 13A). In order to examine the localization in a more 
precise manner, we circled the vesicular structure of Vti1b, recycling TCR and lytic 
granules, and then merged these three circles in a diagram. It showed that in many cases, 
Vti1b was co-localized with LG/rTCR pairs (Fig. 13B, upper panel); occasionally Vti1b 
was co-localized with only lytic granules or recycling TCR in the corresponding LG/rTCR 
pair (Fig. 13B, lower panel). Considering these data we hypothesized that Vti1b is likely to 
be involved in pairing of lytic granules and recycling TCR.  
 
 
 
Figure 13. LG/rTCR pairs are co-localized with Vti1b. (A) Co-localization of Vti1b with LG and eTCR. 
CTLs were pre-incubated with Alexa488-labeled anti-CD3 mAb to label rTCR (green). Perforin was used as 
the LG marker (red). A polyclonal rabbit anti-Vti1b antibody was used to stain endogenous Vti1b. Two 
framed examples of paired vesicles were enlarged in (B), rTCR, Vti1b, LG were circled in green, blue and 
red, respectively. These three circles were merged in the diagram in the far right panel.  
 
4.3.3 The possibility of vesicle pairing was enhanced by Vti1b 
To determine whether Vti1b can affect LG/rTCR pairing, we analyzed the pairing 
possibilities under different circumstances. When lytic granules contain Vti1b, the pairing 
rate is three fold higher than those without Vti1b (Fig. 14). Similarly, when recycling TCR 
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are not co-localized with Vti1b, the possibility for pairing with lytic granules is much 
lower (Fig. 14). This analysis showed that Vti1b enhanced the pairing possibility for both 
lytic granules and recycling TCR compartments.   
 
 
 
Figure 14. Vti1b increases the possibility of vesicle pairing. Vesicles co-localized with or without Vti1b 
are shown as black and gray bars, respectively. From left to right 285, 71, 162 and 139 vesicles in 15 cells 
were analyzed. 
 
 
4.4   Vti1b-dependent tethering of lytic granules and recycling TCR is 
required for CTL cytotoxicity 
4.4.1 Vti1b is required for tethering of lytic granules and recycling TCR 
4.4.1.1 Vti1b expression was down-regulated efficiently by siRNA 
To verify whether Vti1b is essential for the interaction between lytic granules and 
recycling TCR, we used RNA interference technique to down-regulate Vti1b expression. 
One technical difficulty is that the commonly used double-stranded siRNA are not stable 
enough in primary T cells. Recently, a new strategy has been designed to solve this 
problem. Chemical modifications (2’- deoxy-modification, 2’-methoxy-modification, 2’-
hydroxyethylmethylmodification) on certain nucleotides of siRNA make the double 
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strands more stable in primary T cells and this modification of siRNA can efficiently 
down-regulate protein expression in primary T cells 170. Introducing this modification into 
Vti1b-siRNA, we were able to efficiently down-regulate Vti1b in human primary CTLs as 
confirmed by quantitative RT-PCR (Figure 15A), western blot (Figure 15B) and 
immunocytochemistry compared to control siRNA (Figure 16A). We found that Vti1b 
mRNA was reduced to the lowest level between 24 to 36 hours after siRNA 
electroporation and then went up again (Fig. 15A). Accordingly, the protein level of Vti1b 
reached also the low point at 36 hr after siRNA electroporation (Fig. 15B). Therefore 36 
hours after siRNA electroporation was chosen as the time point to examine the impact of 
Vti1b on pairing of lytic granules and recycling TCR.    
 
 
 
Figure 15. Down-regulation of Vti1b by modified siRNA in primary CTLs. (A) Expression of Vti1b was 
down-regulated by siRNA at mRNA level. 6 × 106 SEA-stimulated CTLs were electroporated with 120 pMol 
of control-siRNA or Vti1b-siRNA. At various time points after electroporation CTLs were harvested for 
qRT-PCR. The mRNA level of Vti1b was normalized with three different house-keeping genes. (B) 
Expression of Vti1b was down-regulated by siRNA at protein level. 36 hr after electroporation CTLs were 
collected in sample buffer and sonicated. One representative experiments from three independent 
experiments is shown. 
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4.4.1.2 Down-regulation of Vti1b reduced the pairing rate 
The CTLs transfected with control or Vti1b-siRNA were used 36 hours after 
electroporation. The CTLs were first pre-incubated with Alexa488-conjugated anti-CD3 
antibody to label recycling TCR, and were then fixed and stained with Alexa647-conjugated 
anti-perforin antibody to label the lytic granules. As shown in Fig. 16A, the pairing rate of 
lytic granules was reduced when Vti1b was down-regulated by modified siRNA. The 
quantitative analysis of Fig. 16A showed that in Vti1b-siRNA transfected CTLs the 
number of paired lytic granules reduced to half of the control level, whereas the number of 
single lytic granules increased. However, the total number of lytic granules remained 
unchanged.(Fig. 16B). We conclude that Vti1b is important for pairing of lytic granules 
and recycling TCR compartments.  
 
 
 
Figure 16. The pairing rate of LG was reduced by down-regulation of Vti1b. 36 hr after transfection of 
siRNA, CTLs were fixed and the pairing rate of LG was examined with cell observer. CTLs were pre-
incubated with Alexa488-labeled anti-CD3 mAb to label rTCR. Perforin was used as the LG marker. Non-
silencing siRNA was used as the control for Vti1b-siRNA. (A) Expression of Vti1b is shown in the upper 
panel. Pairing of LG and rTCR is shown in the lower panel. (B) Down-regulation of Vti1b reduced pairing 
rate of LG but not the total LG number.  
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4.4.2 CTL cytotoxicity is impaired by down-regulation of Vti1b 
4.4.2.1 Accumulation of lytic granules at the IS is impaired by down-regulation of 
Vti1b 
To assess whether Vti1b-dependent LG/rTCR pairing is necessary for lytic granules 
accumulation at the IS, we examined lytic granule accumulation at the IS in Vti1b-siRNA 
transfected CTLs. In Vti1b-siRNA transfected CTLs, lytic granules showed a scattered 
pattern 30 minutes after target cell contact, whereas recycling TCR were still enriched at 
the IS as in control siRNA transfected CTLs (Fig. 17). We conclude that down-regulation 
of Vti1b does not affect TCR recycling and reorientation towards the IS, implying that the 
downstream signaling and general polarization mechanisms in Vti1b down-regulated CTLs 
are still functional. Thus, the reduction of LG accumulation at the IS in Vti1b-siRNA 
treated cells is not linked to a general T cell polarization failure but rather to the specific 
impairment in LG/eTCR pairing. 
 
 
Figure 17. Down-regulation of Vti1b impaired the accumulation of LG at the IS. 36 hr after transfection 
of siRNA, CTLs were fixed and the pairing rate of lytic granuels was examined with cell observer. CTLs 
were pre-incubated with Alexa488-labeled anti-CD3 mAb to label rTCR. Perforin was used as the lytic 
granule marker. Non-silencing siRNA was used as the control for Vti1b-siRNA. Proj., the projection of the 
merged stack. BF, bright field. Representative conjugates from three independent experiments are shown.  
Scale bars are 3 µm.  
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To quantify the reduction of lytic granule accumulation at the IS by down-regulation of 
Vti1b in live CTLs, we used TIRF microscopy. In agreement with the confocal microscopy 
results in, in Vti1b-siRNA transfected CTLs the accumulation of lytic granules was 
intensively inhibited, whereas in control siRNA-transfected CTLs, lytic granules showed 
robust accumulation at the IS (Fig. 18).  
 
 
 
 
Figure 18. TIRF microscopy analysis following Vti1b down-regulation. CTLs were transfected with 
perforin-mCherry constructs and Vti1b-siRNA (or non-silencing control siRNA). The cells were used for 
TIRF microscopy 36 hours after transfection. The quantification analysis of LG accumulation is shown in B. 
The TIRF images were acquired every 1 second for 600 seconds. The numbers of lytic granules shown in the 
TIRF plane were quantified. Solid circles, non-silencing control siRNA; Open circles, Vti1b-siRNA. 
Representative examples from three independent experiments are shown. Scale bars are 3 µm. 
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4.4.2.2 CTL-mediated target cell killing is impaired by down-regulation of Vti1b 
We subsequently examined the CTL-mediated target cell killing in Vti1b down-regulated 
CTLs. The CTLs were incubated with SEA-pulsed Raji cells at various effector : target cell 
ratios at 37 °C for 4 hours and then the activity of lactate dehydrogenase (LDH), which is 
released into the supernatant by apoptotic target cells, was determined with the non-
radioactive cytotoxicity assay. Consistent with impaired lytic granule accumulation at the 
IS, the killing capacity of Vti1b siRNA-transfected CTLs showed a significant reduction 
(Fig. 19). Together with the results above, we demonstrate that Vti1b is essential for 
LG/rTCR pairing and is subsequently of great importance for CTL-mediated cytotoxicity. 
 
 
Figure 19. Down-regulation of vti1b impaired CTL cytotoxicity. 36 hr after electroporation CTLs were 
incubated with SEA-pulsed Raji cells at 37 °C for 4 hr with various ratios. Then the supernatant was 
collected for the NonRadioactive cytotoxicity assay. One representative example from three independent 
experiments is shown. 
 
4.5   Vti1b may co-operate with AP-3 to mediate tethering 
Since Vti1b can bind with the epsin receptor 177-178, an adaptor protein in the Golgi 
apparatus. It is possible that lytic granules and recycling TCR compartments may be 
tethered by the interaction between Vti1b and an adaptor protein. Considering the known 
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immune disorders in humans, only the Hermansky-Pudlak syndrome 2 (HPS2), caused by 
deficiency in AP-3 154, has been characterized to be defective in lytic granule accumulation 
at the IS. Lack of AP-3 leads to a scattered pattern of lytic granules in CTLs even after IS 
formation 154, which is similar to our findings in Vti1b down-regulated CTLs (Fig. 17 and 
Fig. 18). Interestingly, similar to Vti1b, AP-3 was not only re-positioned at the IS during 
IS formation, but also co-localized with recycling TCR as well as lytic granules (Fig. 20 A 
and B). Given the fact that AP-3 was also co-localized with Vti1b (Fig. 20C), we propose 
that vti1b and AP-3 could cooperate to regulate LG/rTCR pairing and thus regulate lytic 
granule accumulation and release at the IS. 
 
 
 
Figure 20. Localization of AP-3 in CTLs. AP-3 was co-localized with TCR (A), lytic granules (B) and 
Vti1b (C). SEA-specific CTLs were incubated with SEA-pulsed Raji cells for 15 min and then the samples 
were fixed with ice-cold 4% PFA. Scale bars are 3 µm.  
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4.6   Model for paired vesicle transport 
Our results show that lytic granules and rTCR can be co-transported to the IS. The 
interaction of lytic granules with rTCR is necessary for their efficient docking and release 
at the IS. An important parameter of the immune response is the speed of target cell killing 
by CTLs because it determines the efficiency of cell killing. Using data sets acquired with 
confocal microscopy (as shown in Fig. 2A), we modeled vesicle transport using a 
compartment model as sketched in Fig. 21A and formulated the dynamic changes in the 
various vesicle pools mathematically (Fig. 21B). The rate constants obtained from the 
model (Fig. 21C) predict the numbers of paired and single lytic granules in different areas 
of the cell (for instance in proximity of the IS) over time (solid lines in Fig. 22). These 
predictions are in good agreement with the experimental data (squares and circles in Fig. 
22) indicating that the model is appropriate to fit the data. The model could only fit the 
data well in case the transport rates k1 to k6 were changed between 5 and 10 minutes after 
target cell recognition. The model also shows that 10 minutes after target cell contact the 
LG/rTCR pairing rate k2 increases by a factor of four compared to the early IS formation 
phase, i.e. the first 5 minutes after IS formation; and also k3, the rate of transport paired 
lytic granules to the IS, increases by a factor of four. In contrast, the rates k4 and k5 for 
transport of single lytic granules towards and away from IS, respectively, remained 
unchanged. The model also predicts that 10 minutes after target cell contact, more new 
lytic granules are generated since k1 is increased. Up-to-date imaging approaches, without 
modifying the endogenous proteins, still cannot measure the lytic granule generation in 
vivo. Our model reveals for the first time that after CTLs form a contact with target cells, 
new lytic granules are generated (k1 > 0) to refill the cytotoxic granule pool and 
compensate for the released lytic granules.  
 
4. Results 
____________________________________________________________________________________________________________ 
 
 
 64
Finally the model shows that lytic granules can be released even at the early stage of IS 
formation since k6 = 0.25 min-1 and more than four paired vesicles at the IS imply the 
release of at least one lytic granule per minute. Thus our data and model predict that CTLs 
can kill with a high efficiency within a few minutes using the pairing mechanism because 
it guarantees the rapid and efficient accumulation of lytic granules at the IS.  
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Figure 21. Model for paired vesicle transport. (A) Paired and single lytic granule transport. Pairing is 
required for lytic granule enrichment at the IS and to facilitate their release. k1 is the rate of perforin granule 
production. k2 is the rate of formation of paired vesicles. k3, the rate of movement of paired vesicles to the 
area in the proximity of the IS. k4 is the rate of single vesicles moving to the area in the proximity of the IS; k5 
is the reverse rate of k4. k6 is the rate of paired vesicle release. (B) The formulas to describe changes in the 
different vesicle pools. SM, the single lytic granules in proximity to the IS; PM, the paired lytic granules in 
proximity to the IS; S, the single lytic granules far from the IS (not in proximity to the IS); P, the paired lytic 
granules far from the IS. (C) The parameters used for the compartment model.   
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Figure 22. Paired LG transport model fits the experimental results. CTLs were incubated with SEA-
pulse Raji cells and fixed at 5, 15 and 30 min. Resting CTLs were taken as 0 min. Dots (or squares) are  the 
experimental results. Lines are the predicted curves from the model. (A) Upon increasing time, the number of 
paired LG (squares) at the IS was increasing while the number of single LG (dots) at the IS remained almost 
unchanged. (B) Over time the total number of LG was decreased. The number of both paired (C) and single 
(D) LG not at the IS was decreased.  
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5. Discussion 
This study establishes Vti1b as a mediator for the interaction between lytic granules and 
recycling TCR compartments. A close interaction between lytic granules and recycling 
TCR compartments is required for the accumulation and secretion of lytic granules at the 
IS. Vti1b down-regulation by RNA interference decreased the probability of the interaction 
between lytic granules and recycling TCR compartments, resulting in an impairment in 
accumulation and release of lytic granules at the IS and a reduction in CTL-mediated 
cytotoxicity. 
 
5.1     Significance of tethering of two organelles  
5.1.1 En passant killing 
A very important parameter of the immune response is the speed of target cell killing by 
CTLs because it may determine the outcome of an immune response. Using data from 
confocal experiments that were performed at 37 °C at various time points after contact (as 
shown in Figure 2A), our model predicts that 5 minutes after IS formation the transport 
rate constants are accelerated and that the rate of lytic granule production is increased to 1 
granule per minute. Furthermore, the number of released vesicles increases at a rate of 
about 1 granule per minute immediately after IS formation. We conclude that CTLs need 
only a few minutes to secrete lytic granules at the IS, supporting an en passant killing 
process.  
In line with this prediction, Purbhoo et al. 179 have shown that a mature immunological 
synapse is not required for cytotoxicity. They found that CTLs were able to detect a single 
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foreign antigen, three antigen-MHC complexes were necessary for killing but ten were 
needed for full signaling including a sustained Ca2+ increase. These findings are not easy to 
reconcile with the finding that a full polarization of CTLs, including MTOC translocation 
to the IS, is required for CTLs cytotoxicity 136 because the full polarization of CTLs 
certainly involves sustained signaling. Stinchcome et al.observed a very close apposition 
of MTOC and IS highlighting the role of the MTOC for lytic granule delivery and 
exocytosis. This intimate MTOC-IS contact was observed in 17% of activated CTLs136. 
Considering our new findings and the compartment model, we suggest a hypothetical 
model to reconcile the data by Purbhoo et al. 179 and Stinchcome et al. 136: MTOC 
translocation, which is induced by a strong interaction between CTLs and target cells, can 
guarantee killing but at the cost of time; LG/rTCR tethering-mediated reorientation and 
secretion of lytic granules at the IS enables CTLs to kill more target cells (maybe even in 
parallel) in a shorter time, but with the risk of having a failed killing occasionally. The 
stronger the interaction between CTLs and target cells, the more likely it is that the MTOC 
translocates to the IS leading to the accumulation of all lytic granules at the IS 136, ensuring 
the elimination of the target cells. However, the weak interaction between CTLs and target 
cells, which occurs with less than 10 antigen-MHC complexes, is not able to provide 
strong sustained signaling required for MTOC translocation 179. Nevertheless, transport and 
docking of lytic granules at the IS can still be achieved rapidly by the Vti1b-dependent 
interaction between lytic granules and rTCR. Breaking up of synapses before IS maturation 
and full polarization of CTLs 180-182 can also help CTLs to save time and significantly 
speed up killing. Under physiological circumstances, target cells with high virus load 
(corresponding to the strong CTL-target cell interaction) should be destroyed with a very 
high reliability, which can be assured by full polarization of the killing machinery 
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involving MTOC translocation. On the other hand, for target cells with a relatively low 
virus load (corresponding to the weak CTL-target cell interaction) a rapid killing 
mechanism with a potentially slightly lower reliability may be advantageous. Indeed it has 
been reported that, at low doses of antigen, MTOC reorientation to the IS was decreased 183. 
In this case, the Vti1b-dependent interaction between lytic granules and rTCR provides 
another mechanism to kill these target cells without MTOC reorientation. 
 
5.1.2 Balance between TCR function and TCR down-regulation 
TCR/CD3 complexes are constantly internalized and recycled back to the cell surface. 
TCR recycling has been shown to be crucial for IS formation 184. To fulfill the task to 
eliminate target cells, it is important for CTLs to maintain sensitivity to antigens, which 
requires a certain expression level of TCR/CD3 complexes in CTLs. To detach from killed 
target cells or to refill the exhausted cytotoxic granule pool, CTLs need to down-tune their 
ability to engage with target cells by down-modulating TCR/CD3 expression. It has been 
reported that TCR/CD3 complexes can be targeted to lysosomes by a di-leucine motif 185 
and can be down-regulated after 1 hour of TCR engagement 186. To balance between 
maintainance of functional TCR and antigen-induced TCR down-regulation is a big 
challenge for CTLs. 
Tethering of lytic granules and recycling TCR compartments may be a good solution for 
this problem. By tethering with lytic granules, recycling TCR compartments can quickly 
facilitate the accumulation and release of lytic granules at the IS without being degraded in 
lytic granules. On the other hand, the closer to the IS, the higher calcium influx would be, 
which means that the longer LG/rTCR pairs stay in vicinity of the IS, the higher is the 
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chance they would be exposed to high concentration of calcium. As a result, some time 
after target cell recognition, tethered lytic granules and TCR compartments can fuse after 
which TCR are consequently down-regulated. But it is likely for the fusion of LG/rTCR to 
occur only at the late stage of CTL-target cell engagement. It assures TCR down-regulation 
without jeopardizing initial killing capacity of CTLs.      
 
5.1.3 General signaling mechanism 
The concept of organelle tethering has recently gained much attention, since de Brito and 
Scorrano have shown that mitofusin 2 tethers ER to mitochondria, which facilitates 
efficient mitochondrial Ca2+ uptake 187. In macrophages, a tethering-like structure of 
recycling transferrin receptors and IL-6 containing secretory granules has also been shown 
188. We screened the literature for images of other potentially tethered organelles and found 
hints for paired vesicles also in other cell types, such as mouse embryonic fibroblasts and 
NRK fibroblast cells 189-190. Interaction of different vesicles is usually thought to be a 
transition state right before vesicle fusion. But co-localization of lytic granules and 
recycling TCR compartments was observed only in very few cases in our results, 
indicating that fusion is not necessarily the destined fate for two tethered compartments, in 
other words, rather than just a transit state, interaction of different vesicles can stay as a 
stable structure to fulfill their functions, such as transporting or relocating vesicles.  
Menager et al. reported that cytotoxic function of CTLs required the Munc13-4 mediated 
cooperation of cytotoxic granules and Rab11-positive endosomal ‘exocytic vesicles’ 191. 
Their work highlights the Rab11-mediated recycling pathway for the maturation of 
cytotoxic granules. Our work further verifies that regulatory recycling endosomes ⎯ in 
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particular, TCR-containing recycling endosomes ⎯ play a pivotal role in lytic granule 
release at the IS by tethering with lytic granules and stabilizing them at the IS, thereby 
enhancing the lytic granule release probability. In Munc13-4 deficient CTLs, it is shown 
that lytic granules are still reoriented to the IS but cannot be released 191. In Vti1b-
downregulated CTLs, lytic granules cannot accumulate at the IS because of the impairment 
in tethering with rTCR. These findings suggest that the Vti1b-mediated interaction 
between lytic granules and rTCR compartments is located upstream of Munc13-4 regulated 
cooperation of LG and exocytotic vesicles. 
 
5.2     How Vti1b mediates tethering 
The exact role of Vti1b in vesicle pairing has yet to be elucidated and further studies are 
required to establish its various functions in primary T-cells. However, both in Vti1b 
down-regulated CTLs (Fig. 17 and Fig. 18) and in AP-3 deficient CTLs 154, the re-
orientation of lytic granules at the IS is defective. Furthermore AP-3 and Vti1b are co-
locolized in CTLs and AP-3 is localized with TCR compartments and lytic granules in a 
similar manner as Vti1b (Fig. 20). This data implies that Vti1b may co-operate with AP-3 
to mediate LG/rTCR tethering and thus regulate CTL function. In addition, there are at 
least two other possibilities for Vti1b to regulate pairing. First, it has been reported that 
Vti1b can form oligomers in vitro 192. Vti1b therefore appears to have the capability to 
tether two juxtaposed compartments by homo-interaction. Second, Vti1b can form a trans-
SNARE complex with its cognate SNARE proteins ― syntaxin 7, syntaxin 8, VAMP7 or 
VAMP8 138, which may tether lytic granules and recycling TCR compartments under the 
circumstances inappropriate for vesicle fusion.  
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5.3     What does the model tell us 
Lytic granules are the main weapon that CTLs rely on to eliminate target cells. But many 
questions, such as how quickly CTLs release lytic granules after target cell recognition, 
whether new lytic granules are generated during killing or after killing, are yet to be 
answered. In our study, a compartment model was formulated in the basis of experimental 
data acquired with confocal microscopy. The model predicted that lytic granules are 
released at a rate of 1 lytic granule per minute after contact formation between CTLs and 
the target cells, moreover new lytic granules started to be generated 10 minutes after IS 
formation at a rate of 1.2 granules per minute. It’s the first time to show the dynamic 
information of endogenous lytic granules in vivo. Our results provide an explanation for 
fast CTL killing in a quantitative way. Furthermore, our finding that new lytic granules are 
generated during the killing provides an insight about how CTLs maintain killing capacity 
to eliminate several target cells.  
More importantly, our model revealed that after IS formation, transport of paired lytic 
granules to the IS was accelerated, in contrast, there was not much change in the dynamics 
of single lytic granules. This result further elucidates the functional importance of tethering 
between lytic granules and recycling TCR compartments. The increase in the transport rate 
of LG/rTCR pairs could be contributed by the longer dwell times of paired lytic granules at 
the IS and/or the reorientation of the whole secretory machinery, including MTOC 
relocalization. MTOC relocalization is an energy-consuming process, normaly it takes 
more than 15 minutes 105,136. Therefore, the increase in the transport rate of paired lytic 
granules at the early stage of IS formation ⎯ within 15 minutes after target cell 
recognition ⎯ is likely mediated by longer dwell times of paired lytic granules at the IS.  
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5.4     Why the Golgi apparatus is reoriented to the IS  
Golgi apparatus reorientation to the T cell-target cell interface is one of the first hallmarks 
identified to be required for CTL-mediated killing 115,193. As the Golgi apparatus is the 
main hub for recycling pathways as well as for modifying, sorting and packaging proteins 
for secretion, it is reasonable to assume that reorientation of the Golgi apparatus to the IS is 
to build a shortcut to facilitate delivery of newly generated lytic granules to the IS. But 
until now, not many studies have been done to verify the functions of the Golgi apparatus 
at the IS. Our compartment model suggests that new lytic granules are generated 
immediately after IS formation to refill the cytotoxic granule pool. Very recently 
Makedonas et al. has also shown that newly synthesized perforin rapidly appears at the IS, 
both in association with and independent of cytotoxic granules 194, which is a strong 
support of our prediction.  
Our data show that some LG/rTCR pairs were colocalized with the Golgi apparatus and 
disassembly of Golgi apparatus led to a complete loss of lytic granule accumulation at the 
IS (Fig. 10). This indicates that the Golgi apparatus could be the place for assembly of 
LG/rTCR pairs and that it plays a crucial role in controlling transport of LG/rTCR pairs. 
Potentially the Golgi apparatus generates new lytic granules and then tethers them with 
recycling TCR compartments. Thus, closer the Golgi apparatus is to the IS, lesser is the 
time lytic granules would need to approach the IS and the target cells could be eliminated 
faster. Combining the above two points, we propose that reorientation of the Golgi 
apparatus to the IS enhances the efficiency of CTL-mediated killing.  
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5.5     Error estimation  
5.5.1     The fate of tethered recycling TCR compartments 
In the CTLs recorded with fast 4D microscopy, we never found any separation of the 
paired LG/rTCR. One technical problem we encountered was that the fluorophore Alexa488 
conjugated to anti-CD3 antibody was bleaching relatively quickly with time. To minimize 
the interference caused by bleaching, we recorded the cells only in the first 10 to 15 
minutes after IS formation. Therefore we can not rule out the possibility that detaching of 
paired lytic granules and recycling TCR compartments could occur at a relatively late stage 
of IS formation.  
Our data show that recycling TCR facilitate lytic granule docking at the plasma membrane 
and as a consequence, paired lytic granules are released more frequently at the IS than 
single lytic granules (Fig. 8 and related text). After the lytic granules are released, what is 
the fate of cognate paired recycling TCR compartments? Are they fused with the plasma 
membrane or do they stay docked at the plasma membrane or simply go back to the cytosol? 
From our results acquired by TIRF microscopy, we found that after paired lytic granule 
secretion, the cognate recycling TCR compartment always stayed at the TIRF plane for 
some time. Limited by the resolution of TIRF microscopy, we are not able to distinguish 
the recycling TCR compartments docked at the plasma membrane from the TCR 
microclusters incorporated into the plasma membrane. In addition, the fluorophore 
Alexa488, which is conjugated with the antibody against CD3, is bleached with time during 
recording. Therefore when an Alexa488–conjugated anti-CD3 antibody labeled TCR 
compartment vanishes, it is difficult to judge whether it has fused with the plasma 
membrane or the labeling fluorophore Alexa488 is bleached. Restrained by the technique 
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limitations, the fate of recycling TCR compartments after release of cognate paired lytic 
granules still remains as a question to be further investigated.   
 
5.5.2     Two compartments or two sub-compartments 
In this study, we have resolved that lytic granules and recycling TCR compartments are 
tethered. Whether lytic granules and recycling TCR compartments are localized in two 
different compartments that are tethered together or they are contained in different “sub-
compartments” of a larger organelle cannot be resolved by fluorescence microscopy. 
Interestingly, Peters et al. already showed 20 years ago that endocytosed TCR can be 
associated with the membranes of LG localized in lysosomes, but in a structure distinct 
from the dense core of the lysosomes 195, which most likely contains perforin. This 
suggests that TCR can be sorted into the lytic granule but is in a subcompartment distinct 
from cytotoxic proteins, such as perforin. While we did not find other evidence of a 
distinct localization of perforin and TCR in subcompartments of a common lytic 
compartment, but our data obtained from confocal microscopy, fast deconvolution 
microscopy, and TIRF microscopy can, at present, not rule out this possibility. At this 
point, we cannot distinguish between different subcompartments in one lytic granule or 
tethering of two different organelles. It is however obvious that perforin and rTCR do not 
co-localize. 
 
5.5.3     Secretory domain vs. multifocal IS in human CTLs 
Griffiths and coworkers have reported that in mouse CTLs signaling molecules and lytic 
granules were accumulated at the IS in two spacially seperated domains 19. The distinct 
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secretory domain has been thought to be one prominant feature of CTL-formed IS. We did 
not find the same feature in the IS formed by human CTLs usingTIRF microscopy and 
cofocal microscopy. In human CTLs, lytic granules accumulate at the IS, but not in a 
distinct domain seperated from TCR (see Fig. 1 and Fig. 6), which is the marker for 
cSMAC. The most simple explanation for the discrepancy is that arrangement of the IS in 
human CTLs is different from mouse CTLs. Another possibility is that the status of CTL-
target cell engagement was not the same in two studies. In Griffiths’ work, the mouse 
CTLs were incubated with target cells for 40 to 60 minutes before fixation, however, we 
incubated human CTLs with target cells for only 5 to 30 minutes before fixation. In other 
words, the distinct secretory domain at the IS could also be a feature for late stage of CTL-
traget cell engagement, which is not shown in the early stage of CTL-traget cell 
engagement. We have demonstrated in our study that CTLs can release lytic granules 
quickly, within 5 minutes after target cell recognition (see Fig. 22). Therefore it is unlikely 
that a distinct secretory domain is necessary for lytic granule release.  
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